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Overview 
This thesis investigates the effectiveness of self-management interventions for 
people with severe mental illness. Part one is a systematic review and meta-
analysis of self-management interventions for those with severe mental illness. Part 
two reports on resilience outcomes in a randomised controlled trial of a peer-
delivered self-management program for people recently discharged from crisis care 
(ISRCTN registration: http://www.isrctn.com/ISRCTN01027104). It also investigates 
baseline predictors of resilience. Part three, the critical appraisal, examines the 
concepts of self-management and resilience. It also considers the methodological 
and conceptual challenges of conducting randomised controlled trials of complex 
mental health interventions, particularly in populations where outcomes are largely 
socially determined. 
 
  
 
4 
Table of Contents 
Overview ................................................................................................................ 3 
Acknowledgements ............................................................................................... 7 
Part 1- Literature Review ....................................................................................... 8 
Abstract .................................................................................................................. 9 
Introduction ...........................................................................................................10 
Methods .................................................................................................................13 
Inclusion Criteria .................................................................................................13 
Exclusion Criteria ................................................................................................15 
Search Strategy ..................................................................................................16 
Data Extraction and Quality Assessment.............................................................17 
Statistical Analysis ..............................................................................................18 
Results ..................................................................................................................19 
Narrative Synthesis .............................................................................................21 
Study Characteristics ..........................................................................................21 
Content of Self-Management Interventions: A typology .......................................37 
Outcome measures .............................................................................................40 
Risk of Bias .........................................................................................................42 
Narrative Synthesis Summary .............................................................................43 
Quantitative Synthesis .........................................................................................43 
Quantitative Summary .........................................................................................54 
Discussion ............................................................................................................54 
Strengths and limitations of the review ................................................................56 
Implications for practice .......................................................................................58 
Research implications .........................................................................................59 
References ............................................................................................................60 
Part 2 - Empirical Paper ........................................................................................72 
Abstract .................................................................................................................73 
Introduction ...........................................................................................................74 
The current Study and hypotheses ......................................................................78 
Results ..................................................................................................................89 
Baseline characteristics of participants ................................................................90 
Effect of Peer Support self-management intervention on resilience .....................95 
Univariate and multivariate analysis of predictors of resilience at 18 months .......95 
 
 
5 
Discussion ............................................................................................................99 
Limitations ......................................................................................................... 100 
Strengths ........................................................................................................... 102 
Clinical and Research Implications .................................................................... 103 
References .......................................................................................................... 105 
Part 3 - Critical Appraisal ................................................................................... 113 
Practical challenges in the conduct of large complex interventions.................... 115 
Research Design Issues ................................................................................... 117 
Conclusion ........................................................................................................ 122 
References .......................................................................................................... 123 
Appendix 1: PRISMA Search strategy ............................................................... 126 
Appendix 2.  Full Risk of Bias Assessment ........................................................ 133 
Appendix 3. Forest Plots for select outcomes of meta-analysis ......................... 135 
Appendix 4 Funnel Plots for assessment of Publication Bias (of meta-analyses with 
10 or more studies) ........................................................................................... 139 
Appendix 5. Post-hoc sub-group analysis of TAU only and active control studies
 .......................................................................................................................... 141 
Appendix 6. Ethics Approval .............................................................................. 148 
Appendix 7. 18-month Ethics Approval .............................................................. 152 
Appendix 8. Patient Information Statement and Informed Consent Form .......... 156 
Appendix 9. Recovery Workbook ...................................................................... 167 
Appendix 10: Full baseline interview schedule .................................................. 175 
Appendix 11. Connor Davidson Resilience Scale (CD-RISC-10) ....................... 176 
Appendix 12.  Statement of Joint working .......................................................... 177 
 
List of Tables 
Part 1 
Table 1. Study population and design .....................................................................22 
Table 2. Intervention characteristics organised by proposed types of interventions 29 
Table 3. Summary of self-management intervention typologies ..............................38 
Table 4. Outcomes Measures used in included trials ..............................................41 
Table 5. Analysis of Self-Management Intervention (SM) for people with severe 
mental illness compared to control (active or TAU) ..........................................44 
 
 
6 
Part 2 
Table 1. Baseline demographic characteristics of participants who completed the 
resilience outcome measure at 18 months…………………………………………..…91 
Table 2. Clinical characteristics at baseline of participants who completed the 
resilience outcome measure at 18 months……………………………………………..92 
Table 3. Baseline measures of participants who completed the resilience outcome 
measure at 18 months in each study condition………………………………………...93 
Table 4. Comparison of baseline characteristics of completers and drop-outs…….94 
Table 5. Association between treatment allocation and drop-outs…..…………..…..95 
Table 6. Univariate predictors of resilience after 18 months post discharge from CRT 
care………………………………………………………………………………………….97 
Table 7. Multivariate predictors of resilience after 18 months post discharge from 
CRT care…………………………………………………………………………………...98 
 
List of Figures 
Part 1 
Figure 1. PRISMA flowchart ....................................................................................20 
Figure 2. Cochrane Risk of Bias Summary .............................................................42 
Figure 3. Forest plot of total symptoms at end of treatment ....................................46 
Figure 4. Forest plot of total symptoms at follow-up ................................................46 
Figure 5. Forest plot of depression and anxiety symptoms at end of treatment .......47 
Figure 6. Forest plot of depression and anxiety symptoms follow-up ......................47 
Figure 7. Forest plot of total self-rated recovery at end of treatment .......................48 
Figure 8. Forest plot of total self-rated recovery at follow-up ...................................48 
Figure 9. Forest Plot of functioning at end of treatment  ..........................................50 
Figure 10. Forest plot of functioning at follow-up .....................................................50 
Figure 11. Forest plot of quality of life at end of treatment .......................................51 
Figure 12. Forest plot of quality of life at follow-up ..................................................51 
 
Part 2 
Figure 1. CONSORT flow diagram…………………………………………………..….82 
Figure 2. Scatterplot of resilience (CD-RISC-10) at 18 months and baseline measure 
of recovery (QPR)…………………………………………………………………………96 
  
 
7 
Acknowledgements 
I would like to express an enormous amount of gratitude for all of the 
wonderful people that have contributed to this study. Especially every person who 
kindly gave their time to participate in this study, the peer support workers who 
delivered the intervention, and the CRT staff who work in underfunded services but 
still took time to help recruit participants in the hope to improve services and the 
lives of the people they care for.  
Special thanks to Dr Miriam Fornells-Ambrojo for her expert guidance, 
compassion and sense of humour whilst we gestated together: Miriam- an actual 
human; myself a thesis. A very special thanks to Prof Chris Barker who valiantly 
stepped up to help deliver this thesis in the final months. It has been a most 
enriching and containing experience to work with Chris: academically, personally 
and grammatically.  
To Prof Sonia Johnson and Dr Bryn Lloyd-Evans: thank you for another 
opportunity to work with you both on such a great project and for your input and 
guidance throughout. To my CORE posse of possums (Kate, Danni, Mikey, Becky, 
Marina, Jingyi, Siobhan, Puffin, Liberty and Ruimin) a huge thank you! It was a 
privilege to work with you all and to now call you friends. A special thanks to Dr 
Louise Marston who was very gracious and generous in her time and patience 
teaching me random effects multilevel modelling. 
To my mum, as always thanks for your support- 14 years on still ‘keeping the 
proteins alive’. Matt, Jolene and Alfred- thanks for the pet therapy and company. 
Thanks also to Heidi- who has seen me through another thesis and is still the yin to 
my yang. And finally, to my favourite person, Henry, for always making me laugh 
and for coming home to hold my hand during this final push. 
  
 
8 
 
 
 
 
 
 
 
 
 
 
Part 1- Literature Review 
 
Self-management interventions for people with severe mental illness: a 
systematic review and meta-analysis 
 
 
9 
Abstract 
Aims: Severe mental illness has a considerable and persistent impact on 
individuals, their families and carers. In addition to standard care, self-management 
interventions can assist to empower individuals in their recovery by providing the 
knowledge and skills to enable them to make informed decisions to manage their 
own care. The present review aimed to evaluate the effectiveness of self-
management interventions for adults with Severe Mental Illness (SMI) 
Method: A systematic review and narrative synthesis (n=32 studies) of randomised 
controlled trials of self-management interventions was conducted. A meta-analysis 
(n= 30 studies) of symptomatic, relapse, recovery, functioning and quality of life 
outcomes was conducted using Revman. 
Results: From the narrative synthesis, self-management interventions could be 
classified into five categories: illness management and compliance; bipolar specific 
illness management; transition to community from ward; coping oriented; and 
recovery oriented interventions. From the meta-analysis, self-management 
interventions conferred benefits in terms of reducing symptoms, improving 
functioning and quality of life: both at the end of treatment and sustained at follow 
up. Overall the effect size was small to medium, however a larger effect size was 
seen for symptoms at follow up. There was no evidence that self-management 
decreased risk of relapse as objectively measured, but subjective sense of recovery 
and self-efficacy improved at end of treatment and follow up.  
Conclusion: The provision of self-management interventions alongside standard 
care is likely to be a useful strategy in improving outcomes for people with severe 
mental illness. 
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Introduction 
Severe Mental Illness (SMI) is a category of major psychiatric disorders 
associated with persistently impaired functioning in areas such as work, social 
relationships and self-care (Färdig, Lewander, Fredriksson, & Melin, 2011), and 
includes the diagnoses of schizophrenia, schizoaffective disorder, bipolar, and 
severe depression (DSM–IV, American Psychiatric Association, 2000). The impact 
of SMI at the individual level is wide, ranging from cognitive impairment, social 
isolation and stigma to inequalities in healthcare access, poorer physical health and 
increased mortality (Lawrence & Kisely, 2010). Furthermore, there is a significant 
health and financial burden often experienced by the families and carers of people 
with SMI (Yesufu-Udechuku et al., 2015), as well as a substantial cost to mental 
health services (McCrone, Dhanasiri, Patel, Knapp, & Lawton-Smith, 2008) as 
services face the challenge of meeting a complex mix of clinical and social need.  
Recovery from SMI is often complex and lengthy, and can be understood as 
both a process and an outcome (Deegan, 1989 cited in Torrey, Rapp, Van Tosh, 
McNabb, & Ralph, 2005). The clinical recovery outcomes for people with SMI often 
focus on recurrent relapses and re-admissions, persistence of symptoms (often 
despite taking medication) and ongoing (sometimes lifelong) contact with mental 
health services. For individuals, the process can involve recovering their connection 
with others, their community, and their own sense of meaning, purpose and efficacy 
(Torrey et al., 2005) to progress in life beyond the challenges posed by mental 
illness (Noordsy et al., 2002). The estimated rate of recovery from SMI is contested 
and dependent on a range of factors such as the definition of recovery, outcomes 
evaluated, length of follow up, and setting (Slade & Longden, 2015). Figures have 
ranged from 13.5% clinical recovery in a recent systematic review of recovery in 
schizophrenia (Jääskeläinen et al., 2013) to 46% in a 10-year follow up study of 
people who presented with a first episode of psychosis (Revier et al., 2015). 
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Nevertheless, the impact on individuals in terms of social exclusion (from 
employment and relationships) remains high (Slade & Longden, 2015). 
There are a number of effective treatment approaches for those with SMI 
including psychopharmacotherapy, and psychosocial interventions such as social 
support, family interventions, psychoeducation, cognitive behaviour therapy for 
psychosis, supported employment and social skills training (Mueser & McGurk, 
2004; Oud et al., 2016). However, in spite of the range of interventions available, 
relapse is common, and long term sustained recovery is a reality for few. Illness self-
management interventions draw on elements of these evidence-based practices to 
empower individuals by providing the knowledge and skills to enable them to make 
informed decisions to manage their own care (Mueser & McGurk, 2004), cope with 
symptoms, and reduce susceptibility to relapse and reliance on services (Mueser et 
al., 2002). The largest and most comprehensive review of interventions that improve 
the course of SMI was conducted by Mueser and colleagues in 2002 and identified 
four crucial elements: (i) providing psychoeducation about mental illness and its 
treatment; (ii) behavioural tailoring to facilitate medication adherence; (iii) developing 
a relapse prevention plan; and (iv) teaching coping strategies for persistent 
symptoms.  
The Illness Management and Recovery (IMR) program was developed to 
integrate these four elements into a single, manualised package that can be 
delivered to groups or individuals (Mueser et al., 2006). While this specific 
intervention has been widely delivered across multiple countries and settings, other 
similar self-management interventions have developed independently, many of 
which also incorporate the key elements identified by Mueser and colleagues 
(2002). The result of which is a large body of interventions known as self-
management being delivered to those with SMI, but with little in the way of 
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characterising these interventions in terms of their similarities and differences, or an 
evaluation of their effectiveness.  
Several reviews of self-management interventions have been conducted 
previously, but have tended to focus on broad, non-specific self-management 
interventions such as psychoeducation (Lincoln, Wilhelm, & Nestoriuc, 2007; Zhao, 
Sampson, Xia, & Jayaram Mahesh, 2015) or self-help (Scott, Webb, & Rowse, 
2015), or be confined to specific populations (Zou et al., 2013). A comprehensive 
systematic review and meta-analysis of all studies of self-management interventions 
(defined as those that include Mueser et. al.’s (2002) key evidence-based 
components of self-management) has yet to be done. The present review is the first 
to summarise and synthesise the content of self-management interventions and 
provide a typology to describe the current state of self-management for SMI.  It 
assesses the effectiveness of self-management in the typical mixed populations of 
people with SMI found in NHS secondary care settings. It is likely in the current 
climate of austerity and in the context of increasing service-user choice and 
empowerment that psychosocial interventions will increasingly rely on equipping 
individuals to manage their own mental wellbeing. Furthermore, these interventions 
offer the flexibility to be delivered by peers, in groups, or online. As such it is likely 
that self-management will increasingly become an important treatment approach for 
those with severe mental illness and an understanding of its effectiveness is 
essential. 
Aims 
This paper reviews self-management interventions for populations with Severe 
Mental Illness (SMI) and aims to: 
1. Provide a narrative synthesis of available self-management interventions in 
terms of orientation, essential components, and other defining 
characteristics. 
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2. Review the evidence of the immediate and longer term effectiveness of self-
management in relation to the following outcomes:  
a) Symptomatic recovery  
b) Relapse prevention 
c) Reduced need for hospitalisation  
d) Subjective recovery  
e) Functioning 
f) Quality of Life 
Methods 
A review protocol was developed following PRISMA guidelines (Moher, 
Liberati, Tetzlaff, Altman, & The Prisma Group, 2009) that outlined the research 
question, inclusion and exclusion criteria, search strategy and analysis plan and was 
registered at PROSPERO (Ref: CRD42017043048). There was no funding source 
for this study. 
Inclusion Criteria  
Inclusion criteria were developed using the PICO (Participant, Intervention, 
Comparison, & Outcome) method (Moher et al., 2009): 
Participants 
Studies were included if participants were adults aged 18 years and over and 
diagnosed with a Severe Mental Illness (SMI), that is with a clinical diagnosis of 
schizophrenia spectrum disorders (schizoaffective disorder, delusional disorder and 
psychosis), bipolar disorder, major depression or studies with mixed populations 
(including personality disorder) using secondary care mental health services. 
Participants at any stage of their illness, that is as part of early intervention, or more 
chronic/later stages were included in this review. 
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Intervention 
Studies were included if they featured the delivery of a “self-management 
intervention” directly to service users that was designed to educate and equip 
individuals with the skills to manage symptoms, relapses and overall psychosocial 
functioning (Mueser, Deavers, Penn, & Cassisi, 2013).  Self-management 
interventions could be delivered in conjunction with treatment as usual. In order to 
investigate the effectiveness of self-management itself, interventions with a broader 
focus that included self-management as only one of the intervention components 
were not included in the current review, unless it was possible to ascertain the 
unique impact of self-management. To be considered a self-management 
intervention for the purposes of this systematic review the intervention had to 
include all of the following three domains identified by Mueser and Colleagues 
(Mueser et al., 2002) as effective areas of self-management: 
1. Psychoeducation about mental illness and its treatment (in order to make 
informed decisions about care) 
2. Recognition of early warning signs of relapse and development of a 
relapse prevention plan 
3. Coping skills for dealing with persistent symptoms 
Additionally, the self-management intervention should include a recovery-
focused element such as that defined by Mueser et al. (2013) to set personal goals 
based on an individual’s own hopes for recovery and learn how to effectively 
manage their illness in the context of pursuing those goals. 
Strategies for medication management, the fourth domain identified by 
Mueser and colleagues (2002), was not a necessary domain for a self-management 
intervention to be included into the current review.  
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Comparison 
All randomised controlled trials (RCTs) including cluster RCTs and factorial 
RCTs were considered for inclusion. Quasi randomised studies were excluded. 
Studies employing either treatment as usual or active controls were included in this 
review. 
Outcome 
If studies reported on any of the following outcomes they were included in the meta-
analyses 
1. Symptom-focused outcomes 
2. Relapse (symptomatic relapse, or service use outcomes (admissions; days 
in hospital) 
3. Recovery-focused outcomes (refers to specific measures developed in 
conjunction with service users, that aim to tap participants’ own perceived 
sense of recovery related to concepts such as overcoming “stuckness”, self-
empowerment and efficacy, social connectedness, functioning, overall well-
being, hope and the pursuit of a meaningful life. Separate analyses looked at 
outcomes measuring total self-rated recovery and measures looking at 
individual elements thought to be indicative of recovery such as hope, 
empowerment and self-efficacy). 
4. Functioning (global) 
5. Quality of life 
Exclusion Criteria 
Studies were excluded if:  
1. The intervention had a therapeutic focus beyond that of improving an 
individual’s self-management of their illness (e.g. cognitive remediation, 
cognitive behavioural therapy, basic life skills or social skills) which 
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prevented evaluating the specific efficacy of the self-management 
component. 
2. The intervention was delivered: 
i) to family members (either as the target recipients of the intervention or in 
addition to the service user participants). 
ii) as part of, or alongside another intervention e.g. The Life Goals 
Programme when it was part of the multi-component collaborative care 
model, Life Goals Collaborative Care (LG-CC) (Bauer et al., 2006a, 2006b; 
Bauer, Biswas, & Kilbourne, 2009) was excluded on the basis of the 
additional nurse care management component. 
Search Strategy 
A systematic search for all relevant literature was conducted using a 
PRISMA (Moher et al., 2009) search strategy of the following databases: Medline, 
Embase, PsychINFO, DARE and CENTRAL from their inception until November 
2016. This was part of a broader search of clinical trials originally conducted in 
2012-13 as part of the NICE Schizophrenia Guidelines (National Institute for Health 
and Care Excellence (NICE), 2014b). The relevant parts of this published search 
strategy utilised in the current study are included in Appendix 1. Abstracts were 
screened based on the review protocol and any uncertainties were reviewed by 
supervisor to reach a consensus. The full text of these papers were reviewed to 
ensure they met the criteria specified for inclusion in this review. Twenty percent of 
the full text articles assessed for eligibility (n=63) were blindly assessed to meet 
inclusion and exclusion criteria by a senior member of the research team. The few 
cases of disagreement were discussed and consensus reached. Additionally, a 
hand search of reference lists was conducted. 
 
17 
All abstracts were retrieved and added to Mendeley referencing software 
(Version 1.16.3). 
Data Extraction and Quality Assessment 
Data were extracted and reviewed in Microsoft Excel. Raw outcome data 
extracted from papers published prior to 2012 was kindly provided by the Cochrane 
Collaboration group from the original search conducted as part of the schizophrenia 
guidelines development. The relevant studies and outcome data were then 
extracted according to this current review protocol and checked against the original 
manuscripts. Characteristics of the study design, the intervention, participants and 
outcomes for all available data at all provided time points were extracted. Authors 
were contacted and asked to provide any missing data. Where necessary (i.e. 
unable to obtain original data from authors), outcomes reported as mean difference 
were converted to mean and standard deviation using baseline data where available 
if the number of participants was consistent at both time points. Baseline standard 
deviation (SD) was used as a conservative estimate of SD for the follow up time 
point. When analysing symptoms, depression and anxiety scores for some studies 
were combined to create a composite “Affect” score for anxiety and depression (as 
per Cochrane Handbook table 7.7a (Higgins & Green, 2011). When a study had 
three arms either the active intervention arm or active control arm (depending on 
which met the inclusion/exclusion criteria) was compared to the treatment as usual 
arm in the analysis. For analyses where the pooling of outcome scales were in 
differing directions, the mean of the intervention group was swapped with the mean 
of the control group, which is equivalent to reversing the direction of the scale. For 
the outcomes of functioning, quality of life and recovery, all scores were multiplied 
by -1 so the direction of effect was in line with other analyses in this review (i.e. that 
higher scores indicated a worse outcome). 
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Assessment of Bias 
Assessment of bias was performed using the Cochrane Collaboration Risk of 
Bias Tool (Higgins & Green, 2011). Each study was rated for risk of bias due to 
sequence generation, allocation concealment, blinding of assessors, selective 
outcome reporting and incomplete data. The blinding of participants in trials of 
complex interventions is problematic. As such, it is assumed that blinding of 
participants was at high risk for all studies. Risk of bias was rated as high 
(weakening confidence in results), low (unlikely to seriously alter results) or unclear. 
Publication Bias 
Funnel plots will be generated to examine publication bias in analyses with 
more than 10 studies. 
Statistical Analysis 
Review Manager Software (Revman 5.2) was used to conduct the meta-
analyses. When outcome data was reported for more than one follow-up point, the 
time point closest to 1-year post intervention was used. Where more than one 
outcome measure was used to report an outcome in the same study, we included 
the outcome more commonly reported by other studies in the analysis. On the rare 
event that a study reported both relapse and readmission data, we included the 
readmission data in the analysis. 
Effect Size Calculation 
Effect sizes for continuous data were calculated as standardised mean 
difference, Hedges’ g and studies were weighted using inverse variance. For 
dichotomous outcomes we calculated risk ratios and combined studies using the 
Mantel-Haenszel method (Higgins & Green, 2011). All outcomes are reported with 
95% confidence intervals (CI) using random effects modelling. If reported by studies, 
intention to treat data  was used in the present analysis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
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Heterogeneity 
Heterogeneity of studies was assessed through visual inspection of forest 
plots, the p value of Chi squared test (Q) and calculating the I2 statistic, which 
describes the percentage of the variability in effect estimates that is due to 
heterogeneity rather than chance (Cuijpers, 2016). A p value less than 0.10 and an 
I2 exceeding 50% suggests substantial heterogeneity. Quantifying inconsistency 
across studies in this way allowed us to explore the possible reasons for 
heterogeneity through sensitivity analysis. 
Sensitivity analyses were carried out using the “one-study-removed” method 
to examine the effect of a specific study on the pooled treatment effect. When a 
study was identified as substantially contributing to heterogeneity, the potential 
sources of clinical or methodological heterogeneity were reviewed and compared to 
the remaining studies to evaluate if their exclusion from the particular meta-analysis 
was warranted. 
Results 
Of the 6365 potentially relevant citations, 63 papers were retrieved and 
assessed for inclusion (See figure 1). Of these 14 were excluded because they were 
not mental health self-management interventions (either they did not meet the three 
criteria for inclusion, or covered social skills training only); one study was not 
completed (protocol paper only); and a further 10 papers were outside of the scope 
of this review (i.e. self-management intervention was delivered as part of a trial of 
overall collaborative care model, or included family members in the intervention). 
One paper was included from a reference hand search. Thirty-two randomised 
controlled trials were therefore included in the narrative synthesis (from 39 full-text 
articles). Two studies were not included in the meta-analyses (Eckman et al., 1992; 
Kopelowicz, Wallace, & Zarate, 1998) as they did not report usable outcomes. 
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Records identified through database searching  
(n= 9547) 
Records after duplicates removed  
(n = 6365) 
Records excluded  
(n =6301) 
Titles & Abstracts screened  
(n = 6365) 
Full-text articles excluded  
(n = 25) 
Not mental health self-
management= 14; 
Study not completed= 1; 
Outside the scope= 10 
Studies included in qualitative synthesis 
(n=32; across 39 full-text articles) 
Studies included in quantitative 
synthesis (meta-analysis)  
(n = 30) 
Duplicates Removed:  
(n =3182) 
Full-text articles 
assessed for eligibility 
(n= 63) 
 
 
 
 
 
 
 
 
 
  
Figure 1. PRISMA flowchart 
Articles from 
hand search 
(n= 1) 
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Narrative Synthesis  
 
Study Characteristics 
A detailed breakdown of the characteristics of the studies included in this 
review can be found in Table 1. Studies are grouped according to control group: 
treatment as usual or active. A brief outline of key features are provided below. 
Participants 
Studies included in this review randomised a total of 4961 participants with a 
median sample size of 106 (range 32 to 555). The majority of studies were 
conducted in western countries (k=25), with a smaller but significant proportion in 
Asian and developing countries (k = 7). The majority of studies (k=24) included 
participants that were currently living in the community, with eight studies recruited 
from inpatient settings. 
The mean age was 40 years, suggesting a chronic duration of illness, and 
44% of participants were female.  In relation to clinical diagnosis, 16 studies 
included only participants with schizophrenia spectrum disorder and seven included 
only those with a diagnosis of bipolar disorder. The remaining nine included mixed 
populations of participants with schizophrenia, psychosis, bipolar, major depressive 
disorder and personality disorder. 
 
 
 
 Table 1. Study population and design 
  Sample characteristics Comparator 
Time points† 
(in weeks) 
Study ID Country Context 
Diagnosis‡ 
(% of 
sample) 
Age 
Gender 
% 
female 
Total 
N 
Active 
N 
Intervention Control 
Post-
treatment 
Follow 
up 
Treatment As usual 
ATKINSON 1996 
(Atkinson, Coia, 
Gilmour, & Harper, 
1996) 
UK Community SZ 100% NR 37 146 73 
Education groups for 
People with Schizophrenia 
TAU- Wait list 
control 
20 32 
BARBIC 2009 
(Barbic, Krupa, & 
Armstrong, 2009) 
CAN Community SZ 100% 45 33 33 16 Recovery Workbook TAU 12 NR 
CHIEN 2013 
(Chien & Lee, 2013) 
HK Community SZ 100% 26 45 96 48 
Mindfulness-Based 
Psychoeducation Program 
(MBPP) 
TAU NR 
37; 
102* 
CHIEN 2014 
(Chien & Thompson, 
2014) 
HK Community SZ 100% 26 43 107 36 
Mindfulness-Based 
Psychoeducation Program 
(MBPP) 
TAU & Active 
control (basic 
psychoeducation) 
25 52 
COOK 2011 
(Cook et al., 2011; 
Cook, Copeland, et 
al., 2012; Jonikas et 
al., 2013) 
US Community 
SZ: 21% 
BP: 38% 
MDD: 
25%; 
Other: 
15% 
46 66 555 276 
Wellness Recovery Action 
Planning (WRAP) 
TAU 14 40 
COOK 2012 
(Cook, Steigman, et 
al., 2012; Pickett et 
al., 2012) 
US Community 
SZ: 21%; 
BP:40%; 
MDD: 
18%; 
Other: 
8.6% 
43 56 428 212 
Building Recovery 
of Individual Dreams and 
Goals through Education 
and Support (BRIDGES) 
TAU 14 40 
FARDIG 2011 
(Färdig, Lewander, 
Melin, Folke, & 
Fredriksson, 2011) 
SWE Outpatient SZ 100% 40 46 41 21 
Illness management and 
Recovery program 
TAU 39 91 
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  Sample characteristics Comparator 
Time points† 
(in weeks) 
Study ID Country Context 
Diagnosis‡ 
(% of 
sample) 
Age 
Gender 
% 
female 
Total 
N 
Active 
N 
Intervention Control 
Post-
treatment 
Follow 
up 
HASSON 2007 
(Hasson-Ohayon, 
Roe, & Kravetz, 
2007) 
ISR Inpatient 
SZ: 84%; 
BP: 3%; 
P: 3%; 
Other: 3% 
35 35 210 119 
Illness management and 
Recovery program 
TAU 35 NR 
LEVITT 2009 
(Levitt et al., 2009) 
US Community 
SZ: 32%; 
BP:12%; 
P: 6%; 
MDD:43; 
Other: 7% 
54 37 104 54 
Illness management and 
Recovery program 
TAU: Wait list 22 72 
LIN 2013 
(Lin et al., 2013) 
TWN Inpatient SZ 100% 35 36 97 48 Adapted IMR TAU 3 7 
PERRY 1999 
(Perry, Tarrier, 
Morriss, Mccarthy, & 
Limb, 1999) 
UK Outpatient BP 100% 45 68 69 34 
Teaching patients with 
bipolar disorder to identify 
early symptoms of relapse 
and obtain treatment 
TAU NR 
26, 52*, 
78 
SAJATOVIC 2009 
(Sajatovic et al., 
2009) 
US Community BP 100% 41 62 164 84 Life Goals Program TAU NR 
13; 26; 
52* 
SALYERS 2010 
(Salyers et al., 2010) 
US Community 
P: 55%; 
BP: 10%; 
Other:17; 
missing: 
18% 
42 46 324 183 
Illness management and 
Recovery program 
TAU 52 104 
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  Sample characteristics Comparator 
Time points† 
(in weeks) 
Study ID Country Context 
Diagnosis‡ 
(% of 
sample) 
Age 
Gender 
% 
female 
Total 
N 
Active 
N 
Intervention Control 
Post-
treatment 
Follow 
up 
SHON 2002 
(Shon & Park, 2002) 
KOR Outpatient 
SZ: 55%; 
P: 15% 
Other: 
29% 
33 42 40 20 
Self-Management 
education program 
TAU 12 NR 
SMITH 2011 
(Smith et al., 2011) 
UK Community BP 100% 44 62 50 24 Beating Bipolar TAU NR 43 
TODD 2014 
(Todd, Jones, Hart, 
& Lobban, 2014; 
Todd, Solis-Trapala, 
Jones, & Lobban, 
2012) 
UK Community BP 100% 43 72 122 61 Living with Bipolar (LWB) 
TAU: Wait list 
control 
13; 26* NR 
TORRENT 2013 
(Torrent et al., 2013) 
ESP Outpatient BP 100% 40 
Not 
reported 
268 82 
Psychoeducation + TAU 
Study had 3 arms 
(intervention in original 
study Functional 
Remediation) 
TAU 21 NR 
VAN GESTEL-
TIMMERMANS 2012 
(Van Gestel-
Timmermans, 
Brouwers, van 
Assen, & van 
Nieuwenhuizen, 
2012) 
NL Outpatient 
PD: 31% 
P: 33%; 
other: 
36% 
44 66 333 168 “Recovery Is Up to You” TAU 13 26 
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  Sample characteristics Comparator 
Time points† 
(in weeks) 
Study ID Country Context 
Diagnosis‡ 
(% of 
sample) 
Age 
Gender 
% 
female 
Total 
N 
Active 
N 
Intervention Control 
Post-
treatment 
Follow 
up 
VREELAND 2006 
(Vreeland et al., 
2006) 
US Outpatient SZ 100% NR 55 71 40 Team Solutions TAU 24 NR 
ZHOU 2014 
(Zhou, Zhang, & Gu, 
2014) 
CHN Community SZ 100% 35 47 201 103 
Modules of the UCLA 
Social & Independent 
Living Skills Program 
TAU 26 130 
Active Control 
ANZAI 2002 
(Anzai et al., 2002) 
JPN Inpatient SZ 100% 47 25 32 16 
Social and Independent 
Living Skills Program- 
Community Re-entry 
Module 
Active - 
Conventional 
occupational 
rehabilitation 
program 
9 52 
CHAN 2007 
(Chan, Lee, & Chan, 
2007) 
CH Inpatient SZ 100% 36 0 81 44 
Transforming Relapse and 
Instilling Prosperity (TRIP) 
Active - traditional 
ward occupational 
therapy (WOT) 
programme 
NR 54 
COLOM 2003 
(Colom et al., 2003, 
2009) 
ESP Outpatient BP 100% NR 63 120 60 Psychoeducation + TAU 
Active: 
Unstructured 
support group 
21 
104*; 
260 
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  Sample characteristics Comparator 
Time points† 
(in weeks) 
Study ID Country Context 
Diagnosis‡ 
(% of 
sample) 
Age 
Gender 
% 
female 
Total 
N 
Active 
N 
Intervention Control 
Post-
treatment 
Follow 
up 
COOK 2013 
(Cook et al., 2013a) 
USA Community 
SZ: 26%; 
BP 31%; 
MDD:27%
; Other: 
16% 
46 50 143 72 
Wellness Recovery Action 
Planning (WRAP) 
Active:  Choosing 
Wellness: Healthy 
Eating Curriculum 
9x2.5hr sessions 
9 35 
ECKMAN 1992 
(Eckman et al., 
1992) 
US Outpatient SZ 100% 40 0 41 20 
Social and Independent 
Living Skills Program- 
Medication and Symptom 
Self-management modules 
Active: Supportive 
Group 
Psychotherapy 
26 78 
KOPELOWICZ 1998 
(Kopelowicz et al., 
1998; Mackain, 
Smith, Wallace, & 
Kopelowicz, 1998) 
US Inpatient SZ 100% 35 29 59 28 
Community re-entry 
program 
Active: 
Occupational 
therapy 
group 
NR 5 
PROUDFOOT 2012 
(Proudfoot et al., 
2007, 2012) 
AUS Outpatient BP 100% NR 70 419 139 
Online Bipolar Education 
Program (BEP) + email 
support from expert 
patients known as Informed 
Supporters 
Active: Online 
Bipolar Education 
Program (BEP) 
NR 26 
SALYERS 2014 
(Salyers et al., 2014) 
USA Community SZ: 100% 48 20 118 60 IMR 
Active: 
unstructured 
problem solving 
group 
39 78 
SCHAUB 2016 
(Schaub et al., 2016) 
DEU Inpatient 
SZ: 96%; 
P:4% 
34 47 196 100 
Group-based Coping 
Oriented Program (COP) 
Active: Supportive 
group treatment 
8 
52*; 
104 
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  Sample characteristics Comparator 
Time points† 
(in weeks) 
Study ID Country Context 
Diagnosis‡ 
(% of 
sample) 
Age 
Gender 
% 
female 
Total 
N 
Active 
N 
Intervention Control 
Post-
treatment 
Follow 
up 
WIRSHING 2006 
(Wirshing et al., 
2006) 
US Inpatient SZ 100% 46 2 94 
Not 
reported 
Modified Community Re-
Entry Program 
(CREP) 
Active: Illness 
Education Class 
NR 53 
XIANG 2006 
(Xiang et al., 2006) 
CHN Outpatient SZ 100% 39 51 96 48 
Social and Independent 
Living Skills Program- 
Community re-entry 
module 
Active: Supportive 
counselling 
8 33 
XIANG 2007 
(Xiang et al., 2007) 
CHN Inpatient SZ 100% 39 53 103 53 
Social and Independent 
Living Skills Program- 
Community re-entry 
module 
Active: Group 
psychoeducation 
program 
4 
26; 56*; 
78; 108 
*Time point used in meta-analysis. + Time point of data collection in weeks post randomisation. NR: Not Reported; TAU Treatment as Usual 
 ‡Abbreviations: SZ: schizophrenia or schizoaffective disorder; BP: bipolar disorder; P: psychosis; MDD: major depressive disorder; PD: personality disorder. 
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Interventions 
The characteristics of the self-management interventions included in this 
review, along with a description of each intervention are summarised in table two. 
The studies are organised according to the typology of self-management 
interventions proposed in this review and are outlined in more detail on the following 
pages.  
In all 32 studies, self-management interventions were provided in addition to 
treatment as usual. While the content and scope of the self-management 
interventions included in this review was largely dictated by the inclusion and 
exclusion criteria, there were several areas of variation across studies. In particular, 
the duration of interventions ranged broadly from 1 to 43 weeks (median duration 12 
weeks). Likewise face to face/group contact time also ranged widely from 4 to 96 
hours (median 23 hours). Most interventions were delivered in a group format, and 
facilitated by clinicians (k=22) or peer (k=5). The remaining studies were delivered to 
participants individually, either as an online, computer based intervention (k=2), by a 
clinician (k=1) or by peer (k=1). Finally, one study used a combination of group and 
individual sessions facilitated by clinician. All interventions were delivered from a 
manualised protocol of some form, however the depth, detail and fidelity of the 
intervention to the manual was not always reported in detail. 
Controls 
Self-management interventions were compared to treatment as usual in 18 studies, 
waiting list control conditions in 2 studies and the remaining 12 had active control 
conditions such as group counselling, occupational therapy or psychoeducation 
(Please see table 2 below). 
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Table 2. Intervention characteristics organised by proposed types of interventions 
Study ID Format Facilitator 
# 
sessions 
Duration 
(wks) 
Session 
Length 
(hrs) 
Dose 
(hrs)† 
Intervention Name & Description 
Illness Management and Compliance Interventions 
ATKINSON 
1996 
(Atkinson et 
al., 1996) 
Group Clinician 20 20 1.5 30 Education group 
Sessions alternated between an information session (short presentation and discussion) followed by a 
problem-solving session. Patients were given a manual outlining the content of the sessions, which 
included: The meaning of schizophrenia to the individual, Current understandings and treatment for 
schizophrenia, identifying early signs of relapse and problem solving around managing relapse, 
symptoms, medication & side effects. Problem solving around relationships with friends and family, 
teaching social skills and stress management, and rehabilitation and linking in to community resources. 
CHAN 2007  
(Chan et al., 
2007) 
Group Clinician 10 2 0.8 8 Transforming Relapse and Instilling Prosperity (TRIP) 
Utilizes strategies from IMR however is not a direct derivative of the program. TRIP is an intensive, ward-
based illness management program aims to decrease treatment non-compliance and improve patient's 
insight and health through didactic teaching of information about their illness and open discussion of 
adaptive life and coping skills. Sessions cover two categories i) illness orientated (mental health, 
medication management, relapse prevention planning, symptom management) and ii) health orientated 
(emotion management, rehabilitation resources, healthy living, stress management). 
FARDIG 2011 
(Färdig, 
Lewander, 
Melin, et al., 
2011) 
Group Clinician 40 40 1 40 Illness Management and Recovery (IMR) Program 
Is a clinician led, curriculum based program for service users with SMI. Teaches evidence-based 
techniques for improving illness self-management: psychoeducation, cognitive-behavioural approaches 
to medication adherence, relapse prevention, social skills training (e.g., to enhance social support), 
coping skills training (e.g., for persistent symptoms). Overall aim is to help clients learn about mental 
illnesses and strategies for treatment; decrease symptoms; reduce relapses and rehospitalisation; and 
make progress toward goals and toward recovery. 
 
HASSON 
2007 
(Hasson-
Ohayon et 
al., 2007) 
 
Group Clinician 35 35 1 35 Illness Management and Recovery (IMR) Program 
Follows the standardized curriculum-based approach of IMR. Educational handouts that are a central 
part of the Illness Management and Recovery program were translated into Hebrew and adapted for 
use in Israel. 
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Study ID Format Facilitator 
# 
sessions 
Duration 
(wks) 
Session 
Length 
(hrs) 
Dose 
(hrs)† 
Intervention Name & Description 
LEVITT 
2009 
(Levitt et al., 
2009) 
 
Group Clinician 40 20 1 40 Illness Management and Recovery (IMR) Program 
The standard IMR program was delivered to those living in supportive housing.  
LIN 
2013 
(Lin et al., 
2013) 
Group Clinician 6 3 1.5 9 Adapted Illness Management and Recovery (IMR) Program 
Adapted IMR to fit in-patient acute care setting with the primary focus on symptom and medication 
management, while maintaining a recovery perspective. The adapted IMR program was based on three 
abbreviated modules from the original IMR program: Practical Facts about Schizophrenia, Using 
medication Effectively, and Coping with Problems and Persistent Symptoms. The IMR sessions usually 
started during the third week of hospitalization. Individuals who were discharged from the hospital before 
completing the adapted IMR program were invited to continue with the same IMR group until they had 
completed it. Brief essays about recovery written by individuals who had completed the adapted IMR 
program were also included. 
 
SALYERS 
2010 
(Salyers et 
al., 2010) 
 
Individual 
and group 
Clinician + 
Peer 
43 43 1 43 Illness Management and Recovery (IMR) Program 
This study assessed the effectiveness of IMR when delivered to those receiving Assertive Community 
Treatment. 
SALYERS 
2014 
(Salyers et 
al., 2014) 
 
Group Clinician 39 39 1 39 Illness Management and Recovery (IMR) Program 
Standard program 
SHON 
2002 
(Shon & 
Park, 2002) 
Group Clinician 12 12 1 12 Medication and Symptom Management Education program 
Sessions covered the following key areas: six sessions covered introduction of the psychiatric disorders; 
recognising symptoms and a variety of coping strategies, 3 sessions reinforcing knowledge concerning 
medication use and side effects, and 3 sessions covering relapse warning symptoms and coping skills 
and prevention strategies. Utilised a range of teaching, video vignettes, and small group discussions. 
VREELAND 
2006 
(Vreeland et 
al., 2006) 
Group Clinician 96 24 1 96 Team Solutions Program 
Group based intervention consisting of three, eight-week modules covering the following topics and 
workbooks: i) Understanding Your Illness and Recovering From Schizophrenia; ii) Understanding Your 
Treatment and Getting the Best Results From Your Medication; and iii) Helping Yourself Prevent 
Relapse and Avoiding Crisis Situations. This program was developed by pharmaceutical company Elli 
Lily. 
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Study ID Format Facilitator 
# 
sessions 
Duration 
(wks) 
Session 
Length 
(hrs) 
Dose 
(hrs)† 
Intervention Name & Description 
Bipolar Specific Illness Management 
COLOM 
2003 
(Colom et 
al., 2003, 
2009) 
Group Clinician 21 21 1.5 32 Manual de Psicoeducacion en Tastornos Bipolares 
Aims to prevent recurrences and reduce time spent ill. Addresses four main issues: illness awareness, 
treatment compliance, early detection of prodromal symptoms and recurrences and life style regularity 
through talk on topic of session, exercise related to topic and active discussion. 
TORRENT 
2013 
(Torrent et 
al., 2013) 
Group Clinician 21 21 1.5 31.5 Psychoeducation based on Manual de Psicoeducacion en Tastornos Bipolares 
This psychoeducation intervention (based on Colom, 2003) aimed to prevent recurrences of bipolar 
illness by improving four main issues: illness awareness, treatment adherence, early detection of 
prodromal symptoms of relapse, and lifestyle regularity. Note: study has three arms- Functional 
remediation, psychoeducation and treatment as usual. Functional remediation arm was not included in 
this analysis as it does not meet inclusion criteria. 
SAJATOVIC 
2009 
(Sajatovic et 
al., 2009) 
Group Clinician 6 6 1.25 7.5 Life Goals Program 
The Life Goals Program (LGP) is a manualised, structured group psychotherapy program for individuals 
with bipolar disorder. It is based on behavioural principles from social learning and self-regulation 
theories and focuses on systematic education and individualized application of problem solving in the 
context of mental disorder to promote illness self-management. LGP is organized in two phases which 
cover illness education, management, and problem solving. Phase I is the core psychoeducational 
intervention. The optional phase II group sessions address goal setting and problem solving in an 
unstructured format. 
SMITH 
2011 
(Smith et al., 
2011) 
Individual Computer 8.5 17 NR N/A Beating Bipolar 
The key areas covered in the package are: (i) the accurate diagnosis of bipolar disorder; (ii) the causes 
of bipolar disorder; (iii) the role of medication; (iv) the role of lifestyle changes; (v) relapse prevention 
and early intervention; (vi) psychological approaches; (vii) gender-specific considerations, and (viii) 
advice for family and carers. Online modules were required to be completed in sequential order and 
throughout the trial there was an opportunity for participants in the intervention group to discuss the 
content of the material with each other within a secure, moderated discussion forum. 
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Study ID Format Facilitator 
# 
sessions 
Duration 
(wks) 
Session 
Length 
(hrs) 
Dose 
(hrs)† 
Intervention Name & Description 
TODD 2014 
(Todd et al., 
2014, 2012) 
Individual Computer 10 26 NR N/A Living with Bipolar (LWB) 
LWB is an online interactive recovery informed self-management intervention, broadly based on the 
principles of Cognitive Behavioural Therapy and psychoeducation. The intervention aims to help people 
to: increase their knowledge, self-esteem and self-efficacy around managing bipolar in order to pursue 
personally meaningful recovery goals. Ten interactive modules were developed: (1) Recovery & Me;(2) 
Bipolar &Me; (3) Self-management &Me; (4) Medication & Me; (5) Getting to Know Your Mood Swings; 
(6) Staying well with Bipolar; (7) Depression & Me; (8) Hypomania & Me; (9) Talking about my diagnosis; 
and (10) Crisis &Me. Worksheets were used to enhance learning and personalise the content, and could 
be down- loaded or printed out. Case studies and worked examples, written by service users were used 
extensively to reduce perceived isolation through shared experience. A mood checking tool was 
available for participants to help them identify major changes in their mood. Participants receive 
information about the most appropriate modules, given their mood symptoms. In line with the recovery 
agenda participants were given access to all aspects of the intervention and encouraged to use it as 
and when they felt appropriate. 
PROUDFOOT 
2012 
(Proudfoot et 
al., 2007, 
2012) 
Individual Computer 
and Peer 
email 
8 8 0.5 4 Online Bipolar Education Program (BEP) + Informed Supporters (email support from expert 
patients) 
The online psychoeducation program consisted of topics covering causes of bipolar disorder, diagnosis, 
medications, psychological treatments, omega-3 for bipolar disorder, wellbeing plans, and the 
importance of support networks. It was supplemented by email based coaching and support from 
‘Informed Supporters' (i.e. peers) to answer specific questions or to provide examples of how to apply 
the education material to their everyday lives. Emails focused on effective self-management across three 
domains: medical, emotional and role management, and were linked to the content of the online 
psychoeducation program. Questions of a clinical nature were referred to suitable clinicians. 
PERRY 
1999 
(Perry et al., 
1999) 
Individual Clinician 11.97 9 0.75 9 Teaching patients with bipolar disorder to identify early symptoms of relapse and obtain 
treatment 
Treatment occurred in two stages: collaboratively exploring previous relapses and training the patient to 
systematically identify the idiosyncratic nature and timing of their prodromal symptoms of manic or 
depressive relapse. Diaries were kept to distinguish symptoms associated with normal mood variation 
from prodromes. Once prodromes had been recognised by the patient, an action plan was created and 
rehearsed (such as ways to seek early treatment from a professional). The full relapse plan of warning 
and action stage prodromal symptoms for manic and depressive relapse with the plan for seeking 
treatment was recorded on a card in laminated plastic, which was carried by the patient. 
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Study ID Format Facilitator 
# 
sessions 
Duration 
(wks) 
Session 
Length 
(hrs) 
Dose 
(hrs)† 
Intervention Name & Description 
Transition to Community from Ward 
ANZAI 
2002 
(Anzai et al., 
2002) 
Group Clinician 18 9 1 18 Social and Independent Living Skills (SILS) - Community Re-entry Module 
The Community Re-entry Module consists of sessions on medication management, warning signs of 
relapse and how to develop and implement an emergency plan to deal with relapse, how to find and 
secure housing and continuing psychiatric care in the community, and how to reduce stress and promote 
coping after discharge. The conventional program emphasizes arts and crafts, reality-orientation groups, 
and work assignments in the hospital. 
 
ECKMAN 
1992 
(Eckman et 
al., 1992) 
 
Group Clinician 52 26 1.5 78 SILS- Medication and Symptom management modules 
Utilised two modules from the UCLA Social and Independent Living Skills Program. Medication and 
Symptom Self-management modules 
KOPELO-
WICZ 
1998 
(Kopelowicz 
et al., 1998; 
Mackain et 
al., 1998) 
Group Clinician 8 1 0.75 6 SILS - Community re-entry program 
Based on the UCLA Social and Independent Living Skills Modules and modified for use in the rapid-
turnover, “crisis” operations of a typical acute psychiatric inpatient facility. Sessions focused on preparing 
participants for discharge through teaching knowledge and skills to understand their disorders and the 
medications that control it, to develop an aftercare treatment plan by identifying problems, specifying 
remedial and maintenance services, and linking with service providers, teaching skills to avoid illicit 
drugs, cope with stress, organize a daily schedule, and make and keep appointments with service 
providers. 
ZHOU 
2014 
(Zhou et al., 
2014) 
 
Group Clinician 26 26 2 52 SILS- Medication and Symptom management modules 
The Medication Management and Symptom Management Modules of UCLA program were delivered. 
Additionally, at the end of the intervention, participants were given a self-management check-list journal 
(which monitored medication adherence, sleep, side effects, residual symptoms and signs of relapse) 
and the main caregiver was asked to provide guidance on the process. Participants in the intervention 
group attended monthly self-management group meetings (for 24 months) where community mental 
health workers checked and evaluated their journals.  
WIRSHING 
2006 
(Wirshing et 
al., 2006) 
 
Group Clinician 8 1 1 8 Modified Community Re-Entry Program (CREP) 
Based on the UCLA Community re-entry modules modified to be administered during brief 
hospitalizations to address the immediate needs of a patient who is transitioning back into the 
community.  
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Study ID Format Facilitator 
# 
sessions 
Duration 
(wks) 
Session 
Length 
(hrs) 
Dose 
(hrs)† 
Intervention Name & Description 
XIANG 
2006 
(Xiang et al., 
2006) 
Group Clinician 16 8 1 16 SILS- Community Re-entry Module 
Chinese version of the community re-entry module. 
XIANG 
2007 
(Xiang et al., 
2007) 
Group Clinician 16 4 1 16 SILS- Community Re-entry Module 
Chinese version of the community re-entry module 
Recovery Oriented Self-Management 
BARBIC 
2009 
(Barbic et al., 
2009) 
Group Peer 12 12 2 24 The Modified Recovery Workbook program 
Training uses combination of teaching, group discussion and practical exercises, complemented by a 
workbook for use between sessions. Uses an educational process to increase awareness of recovery, 
increase knowledge and control of the illness, increase awareness of the importance and nature of 
stress, enhance personal meaning and sense of potential, build personal support, and develop goals 
and plans of action. *Note: does not include strategies for medication management 
COOK 2013 
(Cook et al., 
2013a) 
Group Peer 9 9 2.5 22.5 Wellness Recovery Action Planning (WRAP) 
Group sessions consisted of lectures, individual and group exercises, personal sharing and role 
modelling, and voluntary homework to practice using and refining one’s WRAP plan between groups. 
The content of each session is described fully elsewhere (Cook, Copeland, Jonikas et al., 2012), and 
consisted of: (a) the key concepts of WRAP and recovery, (b) personalized strategies to maintain well-
being, (c) daily maintenance plans with simple and affordable tools to foster daily wellness, (d) advance 
planning to proactively respond to self-defined symptom triggers, (e) early warning signs that a crisis is 
impending and advance planning for additional support during these times, (f) advance crisis planning 
to identify preferred treatments and supporters when in acute phases of the illness, and (g) post crisis 
planning to resume daily activities and revise one’s WRAP plan if needed. 
COOK 2011 
(Cook et al., 
2011; Cook, 
Copeland, et 
al., 2012; 
Jonikas et 
al., 2013) 
Group Peer 8 8 2.5 20 Wellness Recovery Action Planning (WRAP) 
Behavioural health illness self-management intervention where participants create an individualized plan 
to achieve and maintain recovery by learning to utilize wellness maintenance strategies, identify and 
manage symptoms and crisis triggers, and cope with psychiatric crises during and following their 
occurrence. Instructional techniques promote peer modelling and support by using personal examples 
from peer facilitators’ and students’ lives to illustrate key concepts of self-management and recovery. 
 
35 
Study ID Format Facilitator 
# 
sessions 
Duration 
(wks) 
Session 
Length 
(hrs) 
Dose 
(hrs)† 
Intervention Name & Description 
COOK 2012 
(Cook, 
Steigman, et 
al., 2012; 
Pickett et al., 
2012) 
Group Peer 8 8 2.5 20 Building Recovery of Individual Dreams and Goals through Education and Support (BRIDGES) 
Course topics included recovery principles and stages; structured problem-solving and communication 
skills training; strategies for building interpersonal and community support systems; brain biology and 
psychiatric medications; diagnoses and related symptom complexes; traditional and non-traditional 
treatments for SMI; and relapse prevention and coping skills. 
VAN GESTEL-
TIMMERMAN
S 
2012 
(Van Gestel-
Timmermans 
et al., 2012) 
Group Peer 12 12 2 24 “Recovery Is Up to You” Course 
Trained peer instructors (at an advanced state of their recovery process) were employed to facilitate this 
group intervention, with discussion and skills practice. Participants used a standardized workbook that 
covered  recovery-related themes: the meaning of recovery to participants, personal experiences of 
recovery, personal desires for the future, making choices, goal setting, participation in society, roles in 
daily life, personal values, how to get social support, abilities and personal resources, and empowerment 
and assertiveness.  Important elements of the course were the presence of role models, 
psychoeducation and illness management, learning from other’s experiences, social support, and 
homework assignments.  
Coping Oriented Self-Management 
CHIEN 
2013 
(Chien & 
Lee, 2013) 
Group Clinician 12 24 2 24 Mindfulness-Based Psychoeducation Program (MBPP) 
The program is a psychoeducational program that addresses patients’ awareness and knowledge of 
schizophrenia and builds skills for illness management. (a) phase 1: orientation and engagement, 
empowerment and focused awareness of experiences, bodily sensations/thoughts and guided 
awareness exercises and homework practices; (b) phase 2: education about schizophrenia care, 
intentionally exploring and dealing with difficulties regarding symptoms and problem-solving practices; 
and (c) phase 3: behavioural rehearsals of relapse prevention strategies, accessible community support 
resources and future plans. 
CHIEN 
2014 
(Chien & 
Thompson, 
2014) 
Group Clinician 12 24 2 24 Mindfulness-Based Psychoeducation Program (MBPP) 
As described above in Chien, 2013 
 
36 
Study ID Format Facilitator 
# 
sessions 
Duration 
(wks) 
Session 
Length 
(hrs) 
Dose 
(hrs)† 
Intervention Name & Description 
SCHAUB 
2016 
(Schaub et 
al., 2016) 
Group Clinician 12 7 1.25 15 Group-based Coping Oriented Program (COP) 
COP seeks to improve understanding of the illness and its treatment, to teach coping strategies for 
specific stressors and symptoms, to activate the use of internal and external resources, and to enhance 
self-confidence and hope. COP combines elements of illness management with cognitive behavioural 
therapy for psychosis. Includes psychoeducation, cognitive-behavioural teaching principles (e.g. 
cognitive restructuring, role playing, problem solving). Thus, the program was intended to foster the 
development of a lifestyle that enhances positive activities and health. COP focused on topics of greatest 
concern to patients, such as symptom-management (e.g., coping with anxiety and positive symptoms), 
managing stress (stress-management including mindfulness and problem solving), building up 
rewarding activities, time management, social skills (e.g., dealing with relatives, getting to know people), 
reintegration into the workplace, and providing information about outpatient services. In early groups, 
participants identified specific distressing symptoms for which coping strategies were selected and 
taught.  
NR – Not reported; N/A – Not Applicable 
# Description of intervention, with assumption that meets 4 criteria (*with exception of Barbic). 
† Total intervention contact time 
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Content of Self-Management Interventions: A typology 
In an attempt to develop a typology of self-management interventions a 
detailed table outlining the format, facilitation and duration of the studies, along with 
the content of each intervention was created (Table 2). From this the common 
elements (largely dictated by the review’s inclusion criteria and previous reviews of 
self-management (Mueser et al., 2002) as well as distinguishing features of each 
intervention) were synthesised into 4 broad categories of self-management 
interventions displayed in Table 3. 
Illness Management and Compliance based Interventions 
Ten studies (Table 2) were categorised as providing an intervention for 
schizophrenia or mixed populations that focused primarily on illness recovery, 
meaning that the skills taught focused on the illness itself and strategies aimed at 
symptom reduction through psychoeducation, relapse prevention planning and 
medication management. These interventions tended to be more problem or “deficit 
focused” (Priebe, Omer, Giacco, & Slade, 2014) in contrast to those categorised as 
recovery oriented programs. The majority of studies in this category utilised the 
Illness management and Recovery based intervention (McGuire et al., 2014), or an 
adapted version of this program. An additional seven interventions in this category 
were developed specifically for the self-management of bipolar disorder. These 
interventions focused on strategies such as in-depth analyses of previous episodes 
to enable participants to track early signs and symptoms of relapse (Janney, Bauer, 
& Kilbourne, 2014), which were incorporated into relapse plans, and an emphasis on 
establishing lifestyle regularity as a way for individuals to manage their illness 
(Murray et al., 2011).  
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Table 3. Summary of self-management intervention typologies 
Proposed Intervention 
Types 
Essential Components 
/Inclusion criteria 
Other defining characteristics 
Psycho-
education 
Relapse 
Prevention 
Coping skills 
Medication 
Management 
Personal 
Recovery Goals 
Peer  
Delivered 
Lifestyle 
Regulation 
Mindfulness 
1.1 Illness management &  
compliance 
     * - - 
1.2 Bipolar specific illness 
management 
     *  - 
2. Transition to community 
from ward 
    - - - - 
3. Coping oriented      - -  
4. Recovery oriented        - - 
Note: Indicates predominant focus of intervention types.  
 Indicates component is present but not the primary focus of this type of intervention 
* Only one study in category utilised peer facilitation (Proudfoot et al., 2012; Salyers et al., 2010) 
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Interventions were predominantly clinician facilitated, with the exception of two 
studies which employed peer support in addition to a clinician facilitator (Salyers et 
al., 2010) or online delivery (Proudfoot et al., 2012). Interestingly this category of 
self-management intervention was the only one to include online delivery of 
interventions for self-management of bipolar (Proudfoot et al., 2012; Smith et al., 
2011; Todd et al., 2014). 
Transition to community from the ward 
Seven studies included in the qualitative synthesis targeted transition from 
the ward into the community. All studies of this type trialled modules from the UCLA 
Social and Independent Living Skills (SILS) Program. This is a highly structured 
behavioural skills training intervention which aims to help individuals reintegrate and 
live in the community at the highest level of functioning possible. The UCLA SILS is 
one of the oldest self-management interventions designed to teach the skills to 
actively seek and obtain one’s own comprehensive community care (Liberman et al., 
1998). As such the main focus is on teaching skills to manage symptoms and 
medication adherence, and building basic skills needed for the transition to the 
community such as how to make and keep appointments and how to foster 
collaboration between service providers and users (Mackain et al., 1998). 
Coping oriented interventions 
In addition to covering the core self-management criteria, three studies 
classified into this category, had content which focused on teaching additional 
coping skills for persistent symptoms and stressors. Two studies incorporated 
mindfulness training as an additional skill to manage persistent symptoms by 
increasing participants’ awareness of, and relationship to, unwanted thoughts, 
sensations and negative feelings (Chien & Thompson, 2014). This is the smallest 
category amongst the typologies however it warranted a separate and distinct 
category due to the unique content of these programs. This category also featured 
more recent studies compared to the other categories and the addition of cognitive 
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approaches and third wave CBT may be a response to the increasing evidence 
base for use of these therapies with service users with severe mental illness. 
Recovery Oriented Interventions 
Five papers were categorised as this type of self-management intervention 
due to the prominent personal recovery orientation. Interventions in this category 
adopted a focus on personal recovery, as opposed to illness recovery, and wellness 
as defined by the individual (Cook et al., 2013), rather than just symptom control 
through adherence to medication or strict learning of behavioural strategies 
(Sterling, Von Esenwein, Tucker, Fricks, & Druss, 2010). Instead a sense of 
meaning, potential and competency was fostered in participants alongside imparting 
knowledge and increasing self-awareness to help manage their condition (Cook et 
al., 2012). Recovery focused interventions were exclusively peer delivered and 
group format. This social aspect to recovery oriented interventions is thought to be 
critical in modelling self-efficacy (Sterling et al., 2010) and empowering individuals to 
change health behaviours (Pickett et al., 2012). 
Outcome measures 
Table 4 outlines the continuous measures used in studies, categorised by 
outcome type. Dichotomous data were also reported. All outcome measures used 
across the studies were reported to be well-validated and reliable instruments. 
Symptom outcomes were reported on measures ranging from self-rated (The 
Internal State Scale (ISS) to those rated by caregivers (PECC) and those requiring a 
clinical interview (PANSS and BPRS). In the majority of studies, relapse was 
measured as an admission to hospital, however a small minority of trials established 
relapse in participants when a score was above cut-off point on a scale (e.g. 
Structured Clinical Interview (SCID) (however only admission data was used in the 
present analysis). Measures of Quality of life were self-rated whereas functioning 
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tended to be clinician rated. Measures of recovery which focused on personal 
recovery as opposed to clinical recovery were exclusively self-rated. 
 
Table 4. Outcomes Measures used in included trials 
Outcome Measure 
 
Total Symptoms Positive and Negative Syndrome Scale (PANSS) 
Brief Psychiatric Rating Scale (BPRS) 
Psychosis Evaluation Tool for Common Use by Caregivers (PECC)  
Internal State Scale (ISS) 
 
Depression & 
Anxiety 
Brief Symptom Inventory (BSI)- Depression  
Psychosis Evaluation Tool for Common Use by Caregivers (PECC)-
Depression- anxiety  
Brief Psychiatric Rating Scale (BPRS)- Depression- anxiety  
Goldberg Anxiety and Depression Scale (GADS)- Depression  
Hamilton Depression Rating Scale (HAM-D)  
Montgomery and Asberg Depression Rating Scale (MADRS)  
Psychological General Well-Being Scale (PGWB)- Anxiety 
Global Assessment of Functioning–Disability Scale (GAF-DIS) 
Structured Clinical Interview (SCID) (DSM-III-R)- Depression 
 
Functioning REHAB scale; 
Social Functioning Scale (SFS);  
Specific Level of Functioning scale (SLOF);  
Global Assessment of Functioning (GAF);  
Social Adaptation Self-Evaluation Scale (SASS);  
Social Disability Screening Schedule (SDSS);  
Social Functioning Interview;  
Work and Social Adjustment Scale (WSAS);  
Global Assessment Scale (GAS) 
 
Quality of Life 
(QoL) 
Quality of Life Scale (QOLS);  
Quality of Life Index;  
Quality of Life Scale- Abbreviated (QLS-A);  
Quality of Life Scale (QLS);  
Quality of Life in BD scale (Brief version) (QoL.BD-Brief);  
Manchester Short Assessment of Quality of Life;  
Psychological General Well-Being Scale (PGWB);  
WHO Quality of Life - BREF: Environmental 
 
Recovery 
 
 
 
 
 
 
 
Overall: Recovery Assessment Scale (RAS);  
Illness Management and Recovery Scales (IMRS);  
Recovery Attitudes Questionnaire (RAQ);  
Bipolar Recovery Questionnaire (BRQ); 
Empowerment Scale;  
Dutch Empowerment Scale;  
International Association of Psychosocial Rehabilitation Services 
(IAPSRS Toolkit);  
Herth Hope Index;  
Coping Efficacy Scale;  
Self- Efficacy Measure;  
Self-Efficacy for Managing Chronic Disease Scale,  
Brief Version (SEMCD); Mental Health Confidence Scale (MHCS) 
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Risk of Bias 
The risk of bias summary is shown in Figure 2 and the risk of bias rating for 
each individual study can be found in Appendix 2. Using the Cochrane Risk of Bias 
Tool (Higgins & Green, 2011) sequence generation was not sufficiently described in 
nine studies. Concealment of the allocation sequence was not sufficiently described 
in 19 studies and high risk of bias in three studies. Blinding of participants and 
personnel is generally considered to be high in complex interventions of this nature. 
As such, all studies except for one (Proudfoot et al., 2012) were rated with a high 
risk of bias. This study (Proudfoot et al., 2012) was rated as low risk for this criterion 
because the intervention was delivered entirely online, featured an active control, 
and outcomes were self-rated, so participants and researchers were not aware of 
their allocation.   Lack of blinding of assessors created a high risk of bias in three 
studies, and in two studies it was unclear if assessors were blind.  Six studies were 
at high risk of bias for missing data (i.e. attrition bias) and four were unclear.  Eight 
studies created a high risk of bias for selective outcome reporting by not clearly 
reporting all outcomes measured, and 17 were unclear. The “other bias” category 
refers to whether any studies were discontinued due to adverse events or problems 
with the study design or acceptability of the intervention. All studies included in this 
analysis were completed as planned and hence were rated as a low risk of bias. 
 
Figure 2. Cochrane Risk of Bias Summary 
 
43 
Narrative Synthesis Summary  
Overall self-management interventions shared similarities, in part dictated by 
the inclusion criteria of this review. Despite this, the narrative synthesis identified 
key differences in the focus and orientation between programs which allowed for the 
development of a typology of self-management interventions. Interventions 
categorised as Illness management and Compliance programs tended to focus on 
clinical recovery and adherence to medication as a necessary aspect to this. Nested 
within this category was the Bipolar Illness management interventions which had an 
additional focus on lifestyle regulation. Bipolar illness management interventions 
were the only type to utilise online delivery. It is not clear why this has proliferated in 
this specific population but not been adopted for use more generally with those with 
severe mental illness. One type of self-management intervention focused on 
transition into the community. Interventions categorised in the recovery and coping 
oriented interventions, tended to be those more recently developed, and their 
approach could be understood as a response to the outstanding need of those with 
SMI in providing additional ways to cope with persistent symptoms. 
In sum, there was a wide variation in the duration, session length and dose 
(contact time) across interventions, and the majority were delivered in the 
community, although a smaller subset were delivered in inpatient settings (with the 
focus on transition to the community). The majority of interventions were 
predominantly delivered in a group format with only a small minority being peer 
facilitated. 
Quantitative Synthesis 
Data were analysed at two time points: at the end of the treatment 
intervention (that is, immediately, or within two weeks of the end of treatment) and at 
follow up (summary of results in Table 5 and forest plots in appendix 3). The median 
follow-up length was 38 weeks (range 4 to 104 weeks) post-treatment; 52 weeks 
(range 7 to 130 weeks) post randomisation. 
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Table 5. Analysis of Self-Management Intervention (SM) for people with severe mental illness compared to control (active or TAU)  
 
Outcome 
Time of data 
collection 
Trials 
(k) 
Participants 
SM/control 
(n) 
E
s
ti
m
a
te
 
Summary of 
estimate  [95% CI] 
Z, p 
Favours 
SM/ 
control 
Heterogeneity 
Q test 
I2 
(%) 
S
y
m
p
to
m
s
 
(1) Total Symptoms 
End of 
treatment 
12 591/553 SMD -0.33 [-0.50, -0.16] 3.75, p = .0002* 
Favours 
SM 
Q = 21.53, p = .03 49† 
Follow-up 10 496/475 SMD -0.81 [-1.18, -0.44] 4.32, p<.0001* 
Favours 
SM 
Q =66.49, p<.001 86† 
Affective Symptoms 
(Depression/Anxiety) 
End of 
treatment 
4 161/145 SMD -0.34 [-0.62, -0.06] 2.41, p = .02* 
Favours 
SM 
Q = 4.35, p=.23 31 
Follow-up 6 475/489 SMD -0.19 [-0.33, -0.04] 2.43, p = .02* 
Favours 
SM 
Q = 5.91, p= .31 15 
R
e
la
p
s
e
 
(2) Mean number of relapses 
(of symptoms or hospitalised) 
 
End of 
treatment 
2 80/75 SMD 0.03 [-0.32, 0.38] 0.18, p = .86 - Q = 1.21, p = .27 18 
Follow-up 3 121/116 SMD -0.37 [-0.88, 0.14] 1.43, p = .15 - Q = 7.54, p = .02 73† 
Total number of participants 
who relapsed during the study 
period 
End of 
treatment 
1 60/60 RR 0.64 [0.44, 0.94] 2.3, p = .02* 
Favours 
SM 
N/A N/A 
Follow-up 9 372/386 RR 0.84 [0.59, 1.19] 0.99, p = .32 - Q = 11.09, p = .20 28 
Length of hospitalisation 
throughout treatment / follow-
up   
End of 
treatment 
2 80/75 SMD -0.44 [-1.34, 0.46] 0.96, p = .34 - Q = 7.65, p<.001 87† 
Follow-up 4 170/189 SMD -0.65 [-1.52, 0.21] 1.48, p = .14 - Q = 45.32, p<.001 93† 
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Outcome 
Time of data 
collection 
Trials 
(k) 
Participants 
SM/control 
(n) 
E
s
ti
m
a
te
 
Summary of 
estimate  [95% CI] 
Z, p 
Favours 
SM/ 
control 
Heterogeneity 
Q test 
I2 
(%) 
R
e
c
o
v
e
ry
 
(3) Recovery - Total 
End of 
treatment 
7 339/293 SMD -0.46 [-0.75, -0.18] 3.16, p = .002* 
Favours 
SM 
Q = 16.87, p = .01 64† 
Follow-up 5 477/479 SMD -0.24 [-0.36, -0.11] 
3.62, p = 
.0003* 
Favours 
SM 
Q = 3.98, p = .41 0 
Recovery - Empowerment  
End of 
treatment 
3 187/159 SMD -1.44 [-2.97, 0.08] 1.86, p = .06 - Q = 44.89, p<.001 96† 
Follow-up 2 278/260 SMD -0.25 [-0.43, -0.07] 2.68, p = .007* 
Favours 
SM 
Q = 1.13, p = .29 12 
Recovery- Hope 
End of 
treatment 
1 132/118 SMD -0.24 [-0.49, 0.01] 1.88, p = .06 - N/A N/A 
Follow-up 3 487/480 SMD -0.24 [-0.46, -0.02] 2.16, p = .03* 
Favours 
SM 
Q = 5.74, p = .06 65† 
Recovery - Self-Efficacy 
End of 
treatment 
4 322/279 SMD -0.38 [-0.62, -0.15] 
3.18, p = 
.0001* 
Favours 
SM 
Q = 5.41, p= .14 45 
Follow-up 1 121/100 SMD -0.34 [-0.61, -0.07] 2.50, p = .01* 
Favours 
SM 
N/A N/A 
F
u
n
c
ti
o
n
in
g
 
(4) Functioning 
End of 
treatment 
10 563/550 SMD -0.39 [-0.69, -0.09] 2.56, p = .01* 
Favours 
SM 
Q = 53.05, p<.001 83† 
Follow-up 11 625/631 SMD -0.55 [-0.92, -0.17] 2.87, p = .004* 
Favours 
SM 
Q = 99.11, p<.001 90† 
Q
o
L
 
(5) Quality of Life 
End of 
treatment 
8 398/377 SMD -0.21 [-0.36, -0.07] 2.95, p = .003* 
Favours 
SM 
Q = 5.5, p = .60 0 
Follow-up 7 491/489 SMD -0.26 [-0.39, -0.13] 4.05,  p<.0001* 
Favours 
SM 
Q = 2.84, p = .83 0 
*Statistically significant finding (p<0.05); † Indicates high heterogeneity: I2 exceeds 50% and/or P value less than 0.10; Note: Random-effects model used 
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Symptoms 
The effect of self-management on psychiatric symptoms was analysed by 12 
studies reporting outcome data on measures of total symptoms for 1144 participants. 
At the end of treatment there was a small but significant benefit of self-management 
over control for total symptoms (SMD: -0.33, 95% CI [-0.50, -0.16]). Heterogeneity for 
this outcome was moderate (I2=49%).  
Figure 3. Forest plot of total symptoms at end of treatment 
At follow up, 10 studies, with 971 participants showed a marked effect of self-
management on total symptoms (SMD= -0.81; -1.18 to -0.44), however this must be 
considered with caution due to the considerable heterogeneity (I2= 86%) displayed 
across the studies.  
Figure 4. Forest plot of total symptoms at follow-up 
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No significant effect was found for self-management when looking at positive 
or negative symptoms subscales separately (please see forest plots Appendix 3). 
When looking at symptoms of depression and anxiety, four studies with 306 
participants favoured self-management both at end of treatment (SMD= -0.34; 95% 
CI [-0.62 to -0.06]) and follow up (SMD= -0.19; 95% CI [-0.33 to -0.04]). 
Heterogeneity (I2) was low, 31% and 15% respectively.  
 
Figure 5. Forest plot of depression and anxiety symptoms at end of treatment 
 
Figure 6. Forest plot of depression and anxiety symptoms follow-up 
 
Relapse 
Overall, self-management interventions did not have a significant effect on the 
rate of relapse or length of hospitalisation across the studies at both end of treatment 
and follow up. There was only one study, a Bipolar specific intervention (Colom et al., 
2003) with 60 participants that reported a significant effect of self-management on 
relapse reduction and hospitalisation at the end of treatment when compared to an 
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active control consisting of an unstructured support group (RR= 0.64; 95% CI [0.44 to 
0.94]). Forest plots for relapse can be found in appendix 3. 
Self-rated recovery 
Seven studies (n= 632) assessed participants overall self-rated recovery at 
end of treatment, and five studies (n = 956) at follow up.  
 
Figure 7. Forest plot of total self-rated recovery at end of treatment 
 
Self-management was favoured over control at both time points with a small 
to medium significant effect size (SMD: -0.46; -0.75 to -0.18] immediately following 
treatment, and a smaller but still significant effect at follow up (SMD= -0.24; -0.36 to -
0.11). Heterogeneity at end of treatment was moderate (I2= 64%), and at follow up 
was very low (I2= 0%). 
Figure 8. Forest plot of total self-rated recovery at follow-up 
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Empowerment  
At the end of treatment, three studies (n=250) reported on the recovery based 
outcome of empowerment. They produced a non-significant SMD of -1.44 (95% CI [-
2.97, 0.08]; z= 1.86, p= .06). Heterogeneity was considerable (I2= 96%). At follow up 
two studies (n= 221) reported on empowerment. The effect size of difference 
between groups was small but significant (SMD= -0.25; -0.43, -0.07). Heterogeneity 
was low (I2= 12%). 
 Hope 
At end of treatment, only one study (n=250) reported on the recovery 
outcome of Hope, which produced a non-significant SMD of -0.24 [-0.49, 0.01], 
z=1.88, p = .06. At follow up three studies with 967 participants showed a small but 
significant effect favouring self-management over control (SMD= -0.24; [-0.46, -
0.02]). Heterogeneity across these studies was substantial (I2= 65%). 
 Self-Efficacy 
Four studies (n= 601) reported on self-efficacy at end of treatment with a 
significant SMD -0.38 (95% CI [-0.62, -0.15], z= 3.18, p< 0.001) favouring self-
management. Heterogeneity was moderate (I2= 45%). Only one study provided data 
for self-efficacy at follow up, which also favoured self-management (SMD-0.34 [-0.61, 
-0.07], z= 2.5, p=.01).  
Forest plots for the recovery outcomes of empowerment, hope and self-
efficacy can be found in Appendix 3. 
Functioning 
Ten studies with 1113 participants provided evidence of a small but significant 
benefit of self-management (SMD= -0.39; -0.69 to -0.09) compared to control on 
functioning of participants immediately following the end of the intervention. 
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Figure 9. Forest Plot of functioning at end of treatment   
 
At follow up (k= 11, n= 1256) this increased to a medium sized effect of self-
management on social and functional disability (SMD= -0.55, -0.92 to -0.17). 
Heterogeneity was substantial for this outcome at both time points, I2= 83% and 90% 
respectively.  
Figure 10. Forest plot of functioning at follow-up 
 
Quality of Life 
Immediately following the end of the intervention, evidence from eight studies 
with 775 participants showed a small but significant effect of self-management on 
participant’s self-rated quality of life (SMD= -0.21; -0.36 to -0.07) which was 
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maintained at follow up (k= 7, n= 980) (SMD= -0.26, -0.39 to -0.13). Heterogeneity 
for both of these analyses was low (I2= 0%). 
 
Figure 11. Forest plot of quality of life at end of treatment  
 
Figure 12. Forest plot of quality of life at follow-up  
 
Heterogeneity and Sensitivity Analyses 
Nine of the twenty meta-analyses had high levels of heterogeneity as 
assessed by an I2 greater than 50% and/or a significant X2 test. Of these, eight 
analyses had more than 3 studies and hence were amenable to the one- study-
removed method (Higgins & Green, 2011) to explore sources of statistical 
heterogeneity. The impact of removing one study sequentially on each meta-analysis 
is reported below, along with an evaluation of potential clinical or methodological 
heterogeneity that may warrant removal of that study from the analyses. 
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Symptoms 
For total symptoms at end of treatment, removal of Chien and Thompson 
(2014) reduced heterogeneity substantially (I2 = 32%). The effect size and 95% CI 
were -0.27 [-0.42, -0.12] (k=11), favouring self-management, as was the case when 
this study was included. This study differed on two important characteristics that may 
have contributed to heterogeneity. This study specifically recruited participants with a 
short duration of illness (less than five years) and excluded those with comorbid 
mental illness. Consequently the study population (which had a mean illness duration 
of 2.6 years) may not be representative of those with long-term or chronic 
schizophrenia (Chien & Thompson, 2014). Furthermore the intervention in this study 
was uniquely distinct as it utilised mindfulness based approaches to coping with and 
managing persistent symptoms. Although Chien & Thompson (2014) differed on 
these characteristics, the overall quality of the study appeared good, with a low risk 
of bias, and as such does not warrant removal. 
At follow up heterogeneity was particularly high, however systematic removal 
of studies did not produce a significant reduction in heterogeneity for this outcome. 
Relapse 
For relapse at follow up, removal of Salyers et al. (2014) reduced 
heterogeneity substantially (I2 = 0%). The effect size and 95% CI were -0.61 [-0.92, -
0.30] (k= 2), now favouring self-management. The heterogeneity may have been a 
product of this study having an active control for which they found no significant 
difference between self-management and the active control, which is in contrast to 
the remaining two studies in this analysis (Chien & Lee, 2013; Chien & Thompson, 
2014) which did find a significant effect for the intervention (compared to treatment as 
usual). These two studies also tested the same intervention (mindfulness based self-
management) in similar populations (those with a duration of illness less than 5 
years). So while the effectiveness of this particular self-management intervention on 
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mean number of relapses may be apparent, the author advises exercising caution to 
extend this effect on relapse to all self-management interventions.  
For length of hospitalisation, heterogeneity was high at both end of treatment 
and follow up, however there were only two studies at end of treatment so 
heterogeneity could not be investigated here. At follow up, systematic removal of 
each study did not impact on heterogeneity which remained high. 
Self-rated recovery 
Similarly, for the total recovery outcome at end of treatment, heterogeneity 
was high and could not be reduced with the systematic removal of each study. For 
empowerment at end of treatment, removal of Barbic et al., (2009) reduced I2= 75%, 
SMD= -0.09; 95%CI [-0.65, 0.47]. For the recovery related outcome of hope at follow 
up, the removal of Van Gestel-Timmermans, Brouwers, van Assen, & van 
Nieuwenhuizen (2012) reduced heterogeneity substantially (I2 = 0%). The effect size 
and 95% CI were -0.13 [-0.28, 0.01] now favouring control. All three studies were 
recovery based self-management interventions, delivered by peer facilitators, and 
were of similar duration and dose. There was no clear rationale justifying the removal 
of this study.   
Functioning 
Again, for the functioning outcome at both end of treatment and follow up, 
heterogeneity was high and remained high after the systematic removal of each 
study. 
In sum, although high heterogeneity was identified in a range of meta-
analyses, evaluation of clinical and methodological characteristics resulted in the 
decision to not remove any of the included studies. 
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Publication Bias 
Funnel plots were created for the four meta-analyses that had more than 10 
studies (Appendix 4). The small number of studies and small number of participants 
in the studies, meant that it was difficult to discern any evident publication bias. 
Quantitative Summary  
In summary, self-management interventions were effective in reducing 
symptoms, improving functioning and quality of life by the end of treatment and this 
was sustained at follow up. Overall the effect size was small to medium, however a 
larger effect size was seen for symptoms at follow up. There was no evidence that 
self-management improved risk of relapse as objectively measured, but subjective 
sense of recovery and self-efficacy significantly improved at end of treatment and 
follow up.  
Discussion 
This is the first comprehensive systematic review and meta-analysis 
evaluating self-management interventions for people with severe mental illness. The 
reviewed evidence suggests that self-management does confer benefits across a 
broad range of outcomes. Specifically, self-management does have a positive impact 
on overall symptoms, and symptoms of depression and anxiety, both at end of 
treatment, and at 1-year follow-up. The effect size for self-management on total 
symptoms is similar to those found in recent meta-analyses of cognitive behavioural 
therapy for psychosis (CBTp): pooled effect size -0.33 [95%CI: -0.47 to -0.19] 
(Jauhar et al., 2014) and 0.40 [95%CI [0.252, 0.58] (Wykes, Steel, Everitt, & Tarrier, 
2008). Since the clinical population and outcome measures used in the present 
review are notably more heterogeneous than those in the CBTp reviews, direct 
comparisons should not be made. However, the CBTp reviews does provide a close 
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approximation of the typical effect sizes that can be achieved in large-scale, complex 
interventions in clinical populations towards the more severe end of the spectrum. At 
longer term follow up (approx. 1 year post intervention) self-management had a large 
effect (SMD=-0.81; 95%CI [-1.18,-0.44]). Due to the high heterogeneity however, it is 
probably more conservative to consider the lower end of the confidence interval as 
indicative of the likely effect size.  
Despite the positive effect on symptoms, this did not translate into significant 
reductions in rates of relapse or length of hospitalisation for self-management 
interventions. This was in contrast to previous meta-analyses of self-management 
interventions for those with schizophrenia (Zou et.al., 2013) who found a significant 
impact on relapse and readmission. This lack of impact on relapse was also in 
contrast to reviews of other interventions, including family intervention for psychosis 
which showed a significant reduction in risk of relapse (up to 12 months) and 
admissions (during treatment) and CBTp which significantly reduced the rate of 
hospitalisations (up to 18 months) following the end of treatment compared to people 
receiving standard care alone (National Institute for Health and Clinical Excellence, 
2009). Although it must be noted that only a small portion of studies, 5 of the 31 
RCTS in the CBTp review measured readmission.  
One way self-management attempts to address relapse prevention is through 
building social support and resilience to stress (Mueser et al., 2013). The role of the 
social environment in the development and persistence of psychotic disorder has 
been well established (Bebbington, 2015). It is possible that the follow up length in 
this review was not long enough for individuals to re-establish both their sense of self 
efficacy in relation to managing their illness, but also to navigating their social 
environment. What this review seems to suggest is that the strategies contained in 
self-management interventions are valuable in helping individuals manage residual 
symptoms and difficulties but is not sufficient to prevent relapses. 
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However, self-management did demonstrate a significant medium sized effect 
on global functioning, and a small but significant effect on quality life at both end of 
treatment and 1-year follow-up. Furthermore, self-management seems to confer a 
small benefit specifically to outcomes valued by consumers (Slade & Longden, 
2015), that is outcomes related to personal recovery, and individual’s sense of 
empowerment, hope and self-efficacy. While the small effect on overall recovery and 
self-efficacy was seen at both end of treatment and follow up, the effect on the 
recovery concepts of empowerment and hope were significant at follow up only. 
Again it could be that individuals require an experience of their self as efficacious 
over time to establish a sense of empowerment and hope in relation to their ability to 
self-manage their illness. Interestingly despite the move towards personal as 
opposed to clinical recovery only a third of studies reported on these outcomes.  
Methodological Limitations of Primary studies  
While all studies included in this review were randomised controlled trials and 
of fair quality, there was variation in the reporting of sequence generation, allocation 
concealment and, as is common in complex interventions, blinding of participants 
and personnel was not always consistent. The greatest cause for concern was the 
selective reporting of outcomes which was noted or not clearly reported in over half 
of the studies reviewed. Furthermore, the small number of studies and small number 
of participants in the studies, meant that it was difficult to discern any evident 
publication bias. These limitations must be considered alongside the findings 
presented in this review to avoid an overestimate of the benefit of self-management. 
Strengths and limitations of the review 
This review gives a broad indication of the effectiveness and potential value 
of self-management interventions for people with severe mental illness. A strength of 
this review is the generalisability of the findings to current practice. For instance, it 
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included a diagnostically heterogeneous sample of people with SMI, representative 
of those presenting in secondary care mental health services, and included samples 
from a wider range of countries and cultures.  
As with any review of this nature, there are methodological limitations that 
must be considered. Heterogeneity was found to be high across many of the meta-
analyses, and while a certain amount of heterogeneity is inevitable, we have tried to 
mitigate this through the use of random effects modelling (Higgins & Green, 2011). 
Additionally, heterogeneity of the outcome measures included in each meta-analysis 
(particularly the self-rated recovery outcomes) means caution should be exercised in 
the interpretation of these findings.  A further potential limitation is from the risk of 
bias quality assessment of the studies included in this review. Interestingly, 
readmission rates and service use outcomes were infrequently measured by studies. 
This could be a useful outcome to include for future studies of self-management.  
The choice to pool together comparisons of self-management against TAU or 
against active controls in the same analyses could be criticised in that they ask quite 
different questions. A post-hoc sub group analysis of TAU only and active control 
only studies was conducted (see forest plots in Appendix 5). No differential pattern of 
outcomes between the different comparators was found. Arguably, TAU varies 
hugely among the included studies, and all of the active controls are treatments 
which might be available from a multi-disciplinary community mental health team.  
Thus, irrespective of whether TAU and active controls are combined or not, the 
analysis is evaluating the addition of self-management to highly varied care. 
In an attempt to present data in a simple format, it was classified into two time 
points: end of treatment and 1-year follow-up. While the follow up time point used in 
this review is intended to indicate the presence of a more enduring effect of self-
management this may not necessarily be the case. This is because not all studies 
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followed up their participants for a full year, and also the time point of data collection 
is measured in weeks post randomisation, not weeks post treatment. Accordingly, the 
variation in intervention length across studies means that for some studies the 1-year 
follow-up time point may in fact be only 6 months post intervention. 
A final limitation in conducting this review was the lack of consensus of how to 
define the concept known as self-management. While this review has to some extent 
attempted to characterise the types of interventions, it unfortunately cannot indicate 
how specific components of these interventions may have been effective. The 
interventions reviewed here are complex, and while they employ overlapping 
techniques, are also likely to vary in their modes of action and their subsequent effect 
on outcomes. In particular, the two studies by Chien and colleagues (2013; 2014) 
that included mindfulness were a departure from the other self-management 
approaches in this review; however, it is important to include studies testing 
additional methods of managing persistent symptoms within the self-management 
context. It could be beneficial to include more mindfulness aspects in future self-
management interventions. In spite of a wide range of self-management interventions 
and some heterogeneity across studies, results appear generally in favour of self-
management.  
Implications for practice 
While self-management for this population has been previously 
recommended at a guideline level (National Institute for Health and Care Excellence 
(NICE), 2014a) (National Institute for Health and Care Excellence (NICE), 2014b), it 
remains to be implemented at a service level. On the basis of this review teaching 
self-management is likely to be a useful strategy and due to its group format, may 
even be a cost-effective approach compared to other currently available interventions 
for this population. It may also provide a first good step in socialising patients to a 
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collaborative way of working that may result in better engagement throughout and 
into subsequent treatment. Providing self-management as a standard part of care, in 
addition to current treatment as usual, could help empower people with severe 
mental illness to feel equipped with the skills, strategies, plans and knowledge to 
effectively live with their illness.  
Research implications 
In terms of future research, it would be important to work to understand the 
mechanisms of effect and critical components of self-management programmes – 
which are multi-faceted, complex interventions. Additionally, further conceptual work 
to establish an optimal typology for self-management interventions is necessary. This 
could involve the further development and validation of the typology proposed in this 
review. 
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Abstract 
Aims: Following mental health crisis there is frequently a lack of continuity of care, 
which is thought to contribute to relapse, and impact on recovery. This study seeks to 
determine if provision of a peer supported self-management intervention following a 
crisis has an effect on resilience at 18 months. It also seeks to determine if any 
baseline characteristics of participants are predictors of resilience at 18 months. 
Methods: In total 441 participants were recruited from Crisis Resolution Teams 
(CRT) across six National Health Service (NHS) Trusts. They were randomised to a 
10-week peer supported self-management intervention utilising a recovery workbook, 
or a control group consisting of the recovery workbook only. At 18-months post-
randomisation, follow-up data was collected for 250 participants. The effectiveness of 
peer support was assessed by comparing the intervention arm to the active control.  
Random effects multilevel modelling with clustering at the peer support level was 
used for the predictors of resilience analysis. 
Results: There was no effect of peer support on resilience at 18 months post-
randomisation. Two variables were found to be predictive of a resilient outcome: 
Social Outcomes Index (SIX) and the Questionnaire about the Process of Recovery 
(QPR), however the amount of change elicited is unlikely to be clinically meaningful 
in terms of improvement in sense of recovery, social functioning or general well-
being. 
Conclusions: The lack of effect in terms of the peer support intervention or in 
identifying predictors of resilience may be related to the complex and interrelated 
factors that have a cumulative, and ongoing, impact on the development of 
resilience. 
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Introduction 
Crisis Resolution Teams (CRTs) provide rapid assessment and treatment of 
mental health crises in the community as an alternative to acute inpatient admission 
(Department of Health, 2001). Published evidence has been predominantly positive 
and suggest that CRTs: reduce inpatient admissions (Glover, Arts, & Babu, 2014; 
Jethwa, Galappathie, & Hewson, 2007; Johnson, Nolan, Hoult, et al., 2005; Johnson, 
Nolan, Pilling, et al., 2005; Keown, Tacchi, Niemiec, & Hughes, 2007); lower 
healthcare costs (McCrone, Johnson, Nolan, Pilling, Sandor, Hoult, McKenzie, 
Thompson, et al., 2009; McCrone, Johnson, Nolan, Pilling, Sandor, Hoult, McKenzie, 
White, et al., 2009) and have been found to increase service user satisfaction with 
acute care (Johnson, Nolan, Hoult, et al., 2005; Johnson, Nolan, Pilling, et al., 2005).  
However, areas of dissatisfaction have also been reported by service users.  
Particular concerns have been raised in relation to the lack of continuity of care 
between services following a crisis (Clark, Khattak, & Nahal, 2008; National Audit 
Office, 2007). CRT care is often experienced by service users as ending suddenly, 
with little in the way of advice or education provided on after-care strategies to 
minimise future crises (Hopkins & Niemiec, 2007). This perceived lack of continuity is 
evident in figures which indicate that a high proportion of service users return to 
acute care within a year of a period of CRT care ending (Johnson, Nolan, Pilling, et 
al., 2005).  
One option to assist in the transition from intensive crisis care to care in the 
community is through the delivery of self-management programs, in particular, peer-
supported self-management programs. There is currently evidence for the 
effectiveness of self-management programs in helping mental health service users to 
develop the skills and strategies to manage their own mental health through 
psychoeducation, developing coping skills to manage persisting symptoms, learning 
to identify early warning signs of crisis and developing ways to respond to crises and 
  
 
75 
other difficulties (Barbic, Krupa, & Armstrong, 2009; Cook et al., 2009; Mueser & 
Gingerich, 2011). Evidence also indicates that the delivery of peer support following a 
mental health crisis; that is support provided by people who have themselves 
experienced mental ill health, alongside existing mental health service support can 
improve outcomes for people (Bowers et al., 2006). 
Peer support is becoming increasingly popular in the UK and abroad, and 
there is substantial evidence for the benefits that it may provide to service users. 
Studies have found that peer support can empower service users to think and 
behave in new ways (Davidson et al., 1999); provide a frame to make sense of their 
experiences (Repper & Carter, 2011); improve social skills and functioning resulting 
in an increased social network (Ochocka, Nelson, Janzen, & Trainor, 2006). 
Additionally, peer support workers are able to forge effective and stable alliances with 
this typically difficult to engage client group (Davidson, Chinman, Sells, & Rowe, 
2006). 
A unique aspect of the peer support relationship is that of reciprocity. This 
refers to the opportunity to receive and give support, which is reported to be highly 
valued by service users. It also represents a shift in the dynamic and power balance 
typically encountered in mental health services (Ochocka et al., 2006). Since peers 
tend to be further along their road to recovery they may instil hope (Davidson, 
Chinman, Sells, & Rowe, 2006), provide opportunities for upward social comparison 
(Wood, 1989) and growth through vicarious learning and the expectation of success 
via exposure to a positive role model (Simoni, Franks, Lehavot, & Yard, 2013). This 
tangible possibility of recovery shared through experiential knowledge (Borkman, 
1976) is something that healthcare professionals and their “professional knowledge” 
may be less able to provide.  
The theoretical underpinnings to account for peer support’s efficacy require 
further development (Simoni et al., 2013) to the extent that peer support has been 
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described “as a method in search of a theory” (Turner &Shepherd, 1999, cited in 
Simoni et al., 2013). Some proposed theories include social support theory, social 
cognitive theory and empowerment theory (Simoni et al., 2013). These theories can 
account for peer support mode of action through the development of an individual’s 
resources to engage in adaptive coping and problem solving (social support theory, 
Cohen & Wills, 1985); increased self-efficacy through vicarious or observational 
learning (Bandura, 1989); and empowerment created through continuity and 
relatedness in connection to others (empowerment theory, Kieffer, 1984). 
Furthermore, support from a similarly situated other may foster self-development, 
decision making skills, and a sense of community. 
The proposed modes of action of peer support have considerable overlap 
with the proposed factors that are thought to contribute to resilience. While resilience 
itself has no single agreed definition (Deegan, 2005), it has been conceptualized as 
both a trait and a process (Luthar, Cicchetti, & Becker, 2007; Windle, Bennett, & 
Noyes, 2011). The most widely agreed definition accepts resilience as a dynamic 
process of positive adaptation to adversity (Luthar et al., 2007) or “bouncing back”. 
The key element to the development of resilience is in the experience of adversity 
and subsequent adjustment. As such those having recently suffered a crisis could be 
well positioned to benefit from an intervention and support that might target 
resilience. Additionally, peer support workers who themselves have overcome 
adversity and recovered (suggesting the development of resilience), may be best 
placed to share their knowledge gained through their experiences. Furthermore, 
investigating resilience in those with severe mental illness (SMI) could be particularly 
relevant given the variation in recovery trajectories between individuals, which may in 
part be accounted for by differences in resilience. 
Much of the research on resilience to date has focused on resilient 
trajectories in relation to children and developmental psychopathology (for an 
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overview see Luthar, Sawyer, & Brown, 2006). There has been little research into the 
role of resilience in the course of severe mental illness (Georgiades, Farquharson, & 
Ellett, 2015; Torgalsbøen, 2012). However, there is preliminary evidence that lower 
levels of resilience are associated with higher levels of persecutory delusions in 
those with early psychosis (Georgiades et al., 2015). It is reasonable to assume, 
although the research has not yet been conducted, that higher levels of resilience 
would be associated with improved recovery outcomes. Additionally, since resilience 
involves behaviours, thoughts and actions that can be learned and developed 
(American Psychological Association, 2015) it potentially could be improved through 
working with a peer support worker to develop self-management skills. 
Resilience varies over the life course- it can be learnt and improved as well as 
eroded by difficult life circumstances (Mental Health Strategic Partnership, 2013). 
Building resilience has been linked to relationships, social connectedness and 
positive social support (Ozbay et al., 2007), as well as neighbourhood social capital 
and environmental factors (Rutten et al., 2013).  These are particularly relevant for 
people with SMI, a notably socially isolated group, disproportionally affected by 
poverty and deprivation (Marmot, 2010). A focus on resilience is an inherently 
strengths-based approach (Rapp, 1998 in Deegan, 2005) a contrast to the deficit-
based model of mental health services. The potential to target resilience through 
peer support and self-management interventions may provide additional means 
through which coping and adapting can be developed as well as foster empowerment 
and hope for service users to make a difference in their recovery (Mental Health 
Strategic Partnership, 2013). 
The employment of peer support workers to deliver self-management 
interventions to service users is becoming increasingly common within NHS services, 
further backed by the recent NICE guidelines (2014) recommendations for the care of 
individuals with psychosis and schizophrenia (NICE, 2014) These guidelines 
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acknowledge the paucity of evidence for peer support and request high quality 
research on peer support programmes. Accordingly, the 2014 NICE guidelines 
research recommendations call for research specifically focusing on the clinical and 
cost effectiveness of peer support interventions in people with psychosis and 
schizophrenia (NICE, 2014). However, to date, there have been no evaluations of 
peer-provided, self-management interventions specifically for people leaving CRT 
care. Furthermore, the benefits of peer provided service are yet to be reliably 
demonstrated to be more effective than current service provision (Lloyd-Evans et al., 
2014). 
 
The current Study and hypotheses 
The CORE (Crisis resolution team Optimisation and RElapse prevention) 
study was a five-year programme of research funded by the National Institute for 
Health Research (NIHR). The study, conducted within NHS crisis resolution teams, 
aimed to optimise team functioning, prevent relapse and enhance recovery. One 
stream of this research programme involved the development and testing of a peer-
delivered self-management intervention that aims to bridge the gap between crisis 
and continuing care.  A multi-site randomised controlled trial (RCT) commenced in 
March 2014. It tested whether a peer-provided, self-management programme and 
recovery workbook compared to a control group receiving the recovery booklet only, 
could reduce relapse and promote recovery for people leaving Crisis Resolution 
Team care. 
In 2015 this study received further funding to collect follow-up data at 18-
months post-randomisation. It was argued that the original data collection point at 
four months post-randomisation may have been too soon post-crisis to capture any 
significant improvement in symptoms or self-rated recovery. In particular, recovery for 
participants with difficulties towards the more severe end of the spectrum, typical of 
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those receiving treatment from Crisis Resolutions teams, is likely to occur over a 
longer time course, due to both the inherent complexity and the variability in the 
clinical course of severe mental illness (Liberman & Kopelowicz, 2005). It was 
hypothesized that collection of data at 18-months could demonstrate any sustained 
effect of peer support on symptoms and self-rated recovery. In addition, it would add 
valuable follow up data for this population group in general, where longer-term 
outcome data is often lacking (Castelein, Bruggeman, Davidson, & Van Der Gaag, 
2015). 
The present study assesses one potential aspect of recovery, resilience, a 
measure of which was added to this project at the 18-month follow-up time point. 
Specifically, this study investigated the effect of peer support following discharge 
from crisis resolution team treatment on resilience. The main research questions 
were: 
1. Did the peer support group differ from the control group (Recovery 
workbook only) on a measure of resilience at 18 months? 
2. What baseline variables predicted resilience at 18 months? 
 
It was hypothesised that participants in the peer support (treatment) group 
would be more likely to show improvements on resilience at the 18-month follow-up 
time point than those in the control group. 
Method 
The findings reported here are drawn from a large cluster Randomised 
Controlled Trial (RCT) (ISRCTN registration: http://www.isrctn.com/ISRCTN 
01027104) that aimed to test whether a peer-provided, self-management programme 
and recovery workbook could reduce relapse and promoted recovery for people 
leaving Crisis Resolution Team care. The present study used the outcome data from 
selected baseline and 18-month follow-up measures. The study had two arms: the 
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intervention arm consisted of a peer supported self-management intervention utilising 
a recovery workbook, and the control arm consisted of the recovery workbook only.  
Setting 
Participants were recruited from Crisis Resolution Teams (CRT) in six 
National Health Service (NHS) Trusts covering inner city, mixed urban and rural 
areas. Peer support sessions and data collection took place in a location convenient 
to the participant, such as their home, an appropriate public space or NHS premises. 
Risk assessments for these sessions were made by clinical CRT staff who knew the 
participant. If risk was identified, then meetings took place on NHS premises only. A 
buddy check-in system was used to ensure researcher safety during home visits. 
 
Recruitment 
A total of 441 participants were recruited to the main CORE study 
(http://www.isrctn.com/ISRCTN01027104). A CONSORT diagram (Figure 1) depicts 
the process of recruitment and follow up of participants through the trial. Of these 441 
participants, 250 completed follow up interviews at 18 months post randomisation. To 
be recruited into the study, participants had to have:  
a) Be over 18 years of age 
b) been on the caseload of a participating CRT for at least one week 
c) had capacity to give written informed consent to the study 
d) been discharged from crisis care within the past month 
Exclusion criteria were: 
a) People who in the view of the clinical team presented such high risk to others, 
that it would be unsafe for peer support workers to meet with them even in a 
mental health service setting.  
b) People who were discharged to addresses outside the catchment area. 
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c) People who could not understand the intervention when delivered in English. 
 
In order to achieve a study sample that was broadly representative of Crisis 
Resolution Team service users, a recruitment threshold was set that stipulated that at 
least 50% of participants must have a diagnosis of schizophrenia, other psychosis, or 
bipolar disorder. Within this stipulation, participation in the study was offered to all 
eligible service users in participating Crisis Resolution Teams until the recruitment 
target for each service was reached.  
 
Ethical Considerations 
Ethical approval was granted by the North-East Research Ethics Committee 
on 19 July 2012 (Ref: 12/LO/0988; Appendix 6).  Subsequent approval for the 
present 18-month follow-up substantial amendment was granted on 18 December 
2015 (see Appendix 7). All participants were provided with a written information sheet 
and the opportunity to discuss with a study staff member (Appendix 8). It was 
reiterated that participation was entirely voluntary. Participants provided written 
informed consent at each time point of data collection.  
Sample Size 
Due to the design of this study, an achieved power calculation was conducted 
retrospectively.  G*Power (Version 3.1.5) statistical software (Faul, Erdfelder, Lang, & 
Buchner, 2007) was used to calculate the level of power achieved given the final 
sample size in this study, that is 125 participants in each arm of the study. 
Accordingly, the sample in this study would have a 99% power to detect a medium 
effect size of d= 0.5, and 76% power to achieve a small effect size of d= 0.3 at a 
p<0.05 level of significance.  
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Figure 1 CONSORT flow diagram 
 
Enrollment 
Screened for Eligibility 
(n=3288) 
Allocated to control group 
 (n=220) 
Allocated to peer support intervention 
(n=221) 
Received intervention of at least 3 
sessions (n=160) 
Did not receive 
intervention (n=61): 
Declined before 1st PSW 
meeting (n=16) 
Unable to contact (n=10) 
Did not attend (n=15) 
Discontinued support after 1 
or 2 sessions (n=9) 
Protocol breach (n=6)  
Other (n=5) 
 
Not Eligible (n= 1440) 
 
Capacity (n=203) 
Risk (n=342) 
Outside area (n=197) 
Language (n=111) 
<7 days with CRT (n=121) 
Hospital dx (n=146) 
Temporary suspension of non-psychosis 
participant recruitment (n= 95) 
Already participating/declined/screened 
(n=157)  
Unable to screen with CRT (n=13) 
Other (n=28) 
Randomised (n=441) 
Eligible but not recruited (n=1407) 
 
Declined (n=581) 
Unable to contact (n=332) 
Out of time (n=373) 
Temporary suspension of non-
psychosis participant recruitment 
(n=102) 
 
18-month Follow-up 
 
Completed (n=128) 
 
Lost to follow-up (n=93) 
Declined (n=40) 
Withdraw (n=1) 
Unable to contact (n=43) 
Deceased (n=1) 
Risk/capacity (n=8) 
 
18-month Follow-up 
 
Completed (n=127) 
 
Lost to follow-up (n=93) 
Declined (n= 50) 
Withdrawn (n=1) 
Unable to contact (n=36) 
Deceased (n=5) 
Risk/capacity (n= 1) 
Allocation 
18-month Follow-up 
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Description of intervention 
Participants allocated to the intervention arm of the study received up to ten 
sessions of tailored self-management guidance delivered by a peer support worker. 
The intervention included both structured and unstructured elements delivered to 
participants through a self-management workbook. The workbook (Appendix 9) 
covered the following: 
 Identifying and setting individual personal recovery goals 
 Help to create plans to re-establish support networks and functioning in the 
community following a crisis 
 Space to reflect on and use recent experience of crisis to identify early 
warning signs and develop an action plan to manage and even avoid relapse 
 Planning strategies and coping resources to maintain wellbeing following a 
crisis 
The self-management workbook was adapted from recovery resources 
compiled by Dr Rachel Perkins and colleagues at South West London and St 
Georges NHS Foundation Trust (Perkins & Rinaldi, 2007) and further informed by 
self-management resources such as the Wellness Recovery Action Plan (Cook et 
al., 2009) and relapse prevention interventions (Birchwood, Spencer, & McGovern, 
2000).  
The peer provision in the intervention arm was designed to help guide 
participants to think about and plan for their recovery using the workbook as a 
framework. The peer support worker was trained to offer empathetic listening, and 
also aimed to instil hope through appropriate sharing of skills and coping strategies 
acquired through their own recovery journey. Peer support meetings took place 
weekly on a one-to-one basis, as arranged between the participant and the peer 
support worker. The entire programme of peer support was delivered within the first 
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three months of participants leaving CRT care. Peer supporters were not matched to 
participants, though participants could opt to see a peer support worker of the same 
gender if they wished. 
 
Peer Support Workers 
Peer support workers, people who themselves had experienced mental 
health problems and used mental health services, were employed to deliver the 
intervention. They were trained in the use of the workbook and how to support 
participants in using it, as well as safety, confidentiality, appropriate self-disclosure, 
roles and boundaries, engagement and listening skills and cultural sensitivity. 
Regular group supervision was provided for the peer support workers facilitated by 
CRT and clinicians.  
  
Control Group 
Participants in the control group were offered a copy of the study self-
management workbook but no additional guidance on how to use it and no meetings 
with a peer support worker. 
Participants in both arms of the study continued to access treatment as 
usual, including medication. 
 
Randomisation 
Once written consent was obtained and baseline measures completed, 
participants were randomly allocated to intervention or control groups using a 
computerised randomisation system (Sealed Envelope Ltd) to block randomise 
participants into treatment and control groups, stratified by site. Senior study staff 
conducted randomisation and informed participants and the CRT about which 
treatment group they had been allocated to. Due to the nature of the intervention the 
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study was single blind.  While it was not possible to blind participants to whether 
they were allocated to the treatment or control group, every effort was made to 
ensure study researchers collecting outcome data were blind to participants’ 
allocation status. For instance, researchers sought to minimise unblinding by 
prompting participants not to disclose which trial group they were in, both when 
setting up interviews and during the interview itself.  
Measures 
Demographics: A structured interview was conducted with each participant 
where descriptive information about the person’s social and demographic 
characteristics: age, gender, ethnicity, accommodation and living situation, 
employment status, educational attainment, past service use and GP contacts over 
the previous three months were collected. Details regarding service use were 
collected from patient records. The full baseline interview schedule can be found in 
Appendix 10. 
The primary outcome variable was measured using the Connor Davidson 
Resilience Scale (CD-RISC-10; Connor & Davidson, 2003: Appendix 11), a self-
rated scale developed for clinical practice to measure resilience and stress coping 
ability. The 10-item version used in the present study (score range 0-40) comprises 
items 1, 4, 6, 7, 8, 11, 14, 16, 17, and 19 from the original scale, and was developed 
on the basis of factor analysis. Sample items were “I am able to adapt when 
changes occur” and “I try to see the humorous side of things when I am faced with 
problems”. Respondents were asked to rate each statement with reference to the 
previous month, understanding that if a particular situation had not arisen in this 
time, then the response should be determined by how the person thinks they would 
have reacted. Items were rated on a five-point scale, ranging from 0 = “not true at 
all” to 4= “true nearly all the time”. Scoring is based on summing all items. Higher 
scores reflect greater resilience. The scale yielded good psychometric properties 
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(internal consistency, convergent and discriminant validity, and construct validity 
(Connor & Davidson, 2003); and in a US general community sample (n=764), the 
mean CD-RISC-10 score was 31.8 (SD=5.47) (Davidson & Connor, 2015). In the 
present study the scale had good reliability: =0.90. 
The Questionnaire about the Process of Recovery (QPR; Neil et al., 2009: 
Appendix 10) is a 22-item measure of self-rated recovery developed in conjunction 
with service users. The questionnaire contains a range of declarative statements 
relating to their mental health and recovery such as “I am able to assert myself”; “I 
am able to develop positive relationships with other people”; and “I can weigh up the 
pros and cons of psychiatric treatment”. Respondents were asked to sum up how 
things stand for them in relation to the statements over the last 7 days on a 5 point 
Likert scale from 0= “disagree strongly” to 4= “agree strongly”. Total scores range 0 
to 88 with higher scores indicative of greater levels of recovery. The QPR is reliable, 
valid and strongly associated with general psychological wellbeing, quality of life and 
empowerment all of which are crucial in recovery from psychosis (Neil et al., 2009). 
The Illness Management and Recovery Scale- patient version (IMR; Mueser 
& Gingerich, 2005: Appendix 10) is a 15-item measure of outcomes targeted by the 
Illness Management and Recovery Program (a self-management program). Each 
item addresses a different aspect of an individual’s illness, its management, and 
personal recovery and includes items such as “How much do your symptoms get in 
the way of doing things that you would like to or need to do” and “in a normal week, 
how many times do you talk to someone outside of your family (like a friend, co-
worker, classmate, roommate etc.)”. Participants are asked to respond on a 5 point 
Likert scale (scored 1-5), with response anchors varying depending on the item. 
Higher scores indicate greater levels of recovery. It has sound psychometric 
properties, however predictive validity of the scales is yet to be assessed (Mueser & 
Gingerich, 2005). 
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The Brief Psychiatric Rating Scale (BPRS; Overall & Gorham, 1962: 
Appendix 10) is a 24-item measure of psychiatric symptoms rated by the interviewer 
based on the participant’s responses to a structured interview schedule. The tool 
consists of 18 symptom constructs such as “somatic concern”, “emotional 
withdrawal”, “unusual thought content” and “blunted affect” that are rated by the 
researcher on a scale from one (not present) to seven (extremely severe). Higher 
scores indicate a higher level of psychopathology. The scale has good psychometric 
properties in terms of reliability and validity (Overall & Gorham, 1962). 
The Social Outcomes Index (SIX; Priebe, Watzke, Hansson, & Burns, 2008: 
Appendix 10) is a four-item objective measure of respondents’ social circumstances 
regarding employment, accommodation, living situation and social contact. 
Participants are requested to respond in relation to their current circumstances to 
four items such as “are you currently employed?” and “Have you met with a friend in 
the last week?”. The response anchors vary depending on the item, for example for 
the employment item possible responses are 0= “none”; 1= “voluntary/ protected/ 
sheltered work”; 2= “regular employment”; whereas friendship responses were 0= 
“No”; 1= “yes”.  The resulting score of SIX ranges from 0 to 6, with a higher score 
indicating a higher level of social capital and outcomes. The SIX does not measure 
a construct, instead the SIX score combines objective responses to very different 
items, thus the total score can be considered a global reflection of social outcomes 
(Priebe et al., 2008). 
The UCLA Loneliness Scale (ULS-8; Hays & DiMatteo, 1987: Appendix 10) 
is an eight-item measure of perceived loneliness. Items include: “How often do you 
feel that there is no one you can turn to?” and “How often do you feel people are 
around you but not with you?”. Respondents are asked to indicate their response on 
a four-point scale ranging from 1= “never” to 4= “always”. A higher score indicates a 
greater level of perceived loneliness. The scale is highly reliable in terms of internal 
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consistency and test-retest reliability and has demonstrated good convergent and 
construct validity (Hays & DiMatteo, 1987). 
The Health and Lifestyles Survey Social Capital Questionnaire (HLSSC; 
Health Education Authority, 1995: Appendix 10) is a six-item measure of 
neighbourhood social capital. Respondents are asked to respond to questions 
regarding their neighbourhood such as “is it a place where you feel personally 
safe?” and “is it a place where neighbours look after each other?”. Response 
options are 1= “yes”, -1= “no” or 0= “don’t know”. A higher score indicates better 
neighbourhood social capital. Information on psychometric properties is not 
available, however the scale forms part of a large national survey (Health Education 
Authority, 1995). 
The Lubben Social Network Scale: Short Version (LSNS-6; Lubben et al., 
2006: Appendix 10) is a six item self-report measure of social engagement with 
family and friends. Items are split into domains of family (e.g. “How many relatives 
do you feel close to such that you could call on them for help?”) and friends (e.g. 
“how many friends do you feel at ease with that you could talk about private 
matters).  Responses are rated on a scale 0= “none” to 5= “nine or more”. Total 
scores range from 0 to 30, individual scoring below 12 are considered to be socially 
isolated. Higher scores indicate higher levels of social engagement with their social 
network. The scale demonstrated high levels of internal consistency, stable factor 
structures, and high correlations with criterion variables when across several 
populations (Lubben et al., 2006). 
Data Collection 
Study measures were completed at baseline, and at the follow-up interview 
four and eighteen months after the baseline interview, once the peer supported, self-
management programme had been completed. The measure of resilience (the 
  
 
89 
Connor Davidson Resilience Scale (CD-RISC-10) was completed at the 18-month 
follow-up interview only. All study measures were completed with participants as a 
structured interview. Participants were offered a £20 gift of cash as an 
acknowledgment of their time and contribution to the study. 
Researcher Role 
This study was part of a programme of research conducted within a large 
research team. My contribution to the work involved adding to the follow-up research 
design with the addition of the resilience measure to the study protocol, along with 
obtaining substantial amendments to the existing ethics approval. During data 
collection, I worked in a coordinator role overseeing progress of recruitment and 
data collection, providing consultation in relation to ways to streamline and increase 
recruitment. I also contributed to recruitment by contacting “difficult to reach” 
participants outside of business hours (i.e. in the early evening) to catch participants 
who may work during the day. All other aspects of the research were distinct and 
independent. 
Results 
At follow up, data was collected from 255 participants, with 250 having 
usable data for this study. Baseline characteristics of the patients in each group 
(peer support versus control) were summarised using descriptive statistics. 
Histograms of the distribution of the outcome variables were inspected visually. All 
were sufficiently close to normal distribution to justify using parametric statistics. 
Chi-square or t-tests, as appropriate, were used to check for differences between 
groups. An alpha level of .05 was used for all statistical tests.  
To assess the effectiveness of the peer support self-management 
intervention on resilience, the intervention arm was compared to the active control 
arm using a two-sample t-test with equal variances.  Random effects multilevel 
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modelling with clustering by the peer supporter was used for the predictors of 
resilience analysis. Multilevel modelling was necessary because the participants 
were naturally nested within groups - by treatment arm; severity of mental health 
(psychosis or not); NHS trust; and peer support worker- which violates the 
assumption of independence, required for ordinary least square regression and 
which would otherwise overstate the statistical significance (Nezlek, 2008). For the 
dependent variable resilience (CD-RISC-10), at least 7 of the 10 items needed to be 
completed in order to consider the scale usable. For missing answers, the mean of 
all completed answers was used to impute the score. 
 
Baseline characteristics of participants 
 
As outlined in Table 1, the mean age of the 250 participants was 40 years 
(range 18 to 75) and 60% (n=149) were female. The majority (63%; n= 156) were 
white British or from another white ethnic background, while the remaining 37% (n= 
93) were of black, Asian or mixed ethnicity. A small minority of participants were 
married or cohabiting (26%; n= 64), with the remaining 74% (n=186) being single, 
separated or divorced. In terms of educational attainment, 55% (n= 136) had a 
school level education or below and 45% (n= 113) had a post school qualification 
such as a Higher National Diploma (HND), degree or postgraduate qualification. 
In terms of baseline demographics there was no difference between 
participants randomised to receive the peer support intervention and those that were 
allocated to the control group (Table 1). 
In relation to clinical features (Table 2), the majority of participants had 
diagnoses of schizophrenia, psychosis or bipolar affective disorder, followed closely 
by depressive and anxiety disorders. Fifteen percent of participants (n= 37) had a 
diagnosis of personality disorder. In terms of service use, 36% (n=91) had never 
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had an admission to a psychiatric hospital. Of the 64% (n= 158) of participants who 
had had an admission once or more over their lifetime, 38% (n=96) had been 
compulsorily detained. 
Table 1. Baseline demographic characteristics of participants who completed 
the resilience outcome measure at 18 months 
Variable 
Totala 
N=250 
Peer Supportb 
N= 125 
Controlb 
N= 125 
Statistical 
Test (df) 
p 
Age M(SD) 40.0(12.3) 39.9 (12.6) 40.12(12.1) t(248) = 0.13 0.90 
Gender      
Male 
Female 
101 (40) 
149 (60) 
54 (43) 
71 (57) 
47 (38) 
78 (62) 
2(1) = 0.81 0.37 
Ethnicity      
White British 130 (52) 59 (47) 71 (57) 
2(4) = 3.06 0.55 
White other 26 (11) 15 (12) 11 (9)  
Black/Black British 53 (21) 28 (23) 25 (20)  
Asian/Asian British 24 (10) 13 (10) 11 (9)  
Mixed 16 (6) 10 (8) 6 (5)  
Marital Status      
Married or cohabiting 64 (26) 31 (25) 33 (26) 2(3) =  4.58 0.21 
Single 153 (61) 73 (59) 80 (64)   
Separated or divorced 30 (12) 18 (14) 12 (10)   
Widowed 3 (1) 3 (2) 0 (0)   
Highest Level of Education attainment   
School Leaver (no 
qualifications) 
40 (16) 21 (17) 19 (15) 2(5) =  3.97 0.55 
GCSE’s or equivalent 49 (20) 24 (19) 25 (20)   
A levels or equivalent 47 (19) 26 (21) 21 (17)   
HND or professional 
qualification  
30 (12) 18 (14) 12 (10)   
Degree 53 (21) 23 (18) 30 (24)   
Post-Graduate Degree 30 (12) 12 (10) 18 (14)   
a All results are n (%) unless otherwise indicated 
b variations in N due to missing data 
 
In terms of previous contact with crisis resolution team support, 49% (n= 121) of 
participants had one other period of support in the community from a crisis 
resolution team, while 51% (n=128) had two or more periods of support previously. 
While 15% of participants (n= 38) had been in contact with mental health services 
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for less than 3 months, the majority (52%; n= 130) had been in contact with services 
for more than 5 years. A sizeable proportion of all participants (35%; n= 87) had 
been in contact with services in excess of 10 years.  
Table 2. Clinical characteristics at baseline of participants who completed the 
resilience outcome measure at 18 months 
 
Variable Total
a 
PeerSupport b 
N= 125 
Controlb 
N= 125 
Statistical 
Test (df) 
p 
Severe Mental Illness      
Psychotic Disorder 117 (47) 63 (50) 54 (43) 2(1) = 1.30 0.25 
Other mental illness (non-
psychosis) 
133 (53) 62 (50) 71 (57)   
Diagnosis      
Psychosis 60 (25) 32 (26) 28 (23) 2(4) = 1.49 0.83 
Bipolar Affective Disorder 
(Manic Episode) 
41 (17) 23 (19) 18 (15)   
Depressive/Anxiety 
Disorder 
88 (36) 44 (35) 44 (37)   
Personality Disorders 37 (15) 16 (13) 21 (17)   
Other 18 (7) 9 (8) 9 (8)   
Lifetime admissions to psychiatric hospital    
Never 91 (36) 40 (32) 51 (41) 2(3) = 3.02 0.38 
Once 57 (23) 33 (26) 24 (19)   
2 to 5 times 67 (27) 33 (26) 34 (27)   
More than 5 times 34 (14) 19 (16) 16 (13)   
Lifetime compulsory admissions to psychiatric hospital   
Never 154 (62) 78 (62) 76 (61) 2(3) = 1.59 0.65 
Once 42 (17) 18 (14) 24 (19)   
2 to 5 times 41 (16) 21 (17) 20 (16)   
More than 5 times 13 (5) 8 (7) 5 (4)   
Periods of support from Crisis resolution teams   
1 121 (49) 64 (52) 57 (45) 2(4) = 2.85 0.58 
2 51 (20) 24 (19) 27 (22)   
3 to 5 52 (21) 26 (21) 26 (21)   
6 to 10 14 (6) 7 (6) 7 (6)   
More than 10 11 (4) 3 (2) 8 (6)   
Total length of contact with services    
Less than 3 months 38 (15) 18 (14) 20 (16) 2(5) =11.01 0.051 
3 months-1 year 22 (9) 15 (12) 7 (6)   
1-2 years 18 (7) 9 (7) 9 (7)   
2-5 years 42 (17) 13 (10) 29 (23)   
6-10 years 43 (17) 26 (21) 17 (14)   
More than 10 years 87 (35) 44 (35) 43 (34)   
a All results are n (%) 
b variations in N due to missing data 
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From the clinical outcome measures taken at baseline (Table 3), the majority 
of these measures were chosen for their ability to reflect change over time. In this 
present study only some of the measures were of note in relation to a clinical picture 
of participants. Participants mean symptom scores measured on the BPRS place 
the group in the “moderately ill” clinical global impression range (Leucht et al., 
2005). On the Lubben Social Network Scale all groups scored below 12, the cut- off 
at which individuals could be considered to be socially isolated. 
The data in Table 3 demonstrate that there was no significant difference, in 
terms of baseline functioning (symptom severity, social capital and recovery) 
between the two groups, with the exception of the Health and Lifestyles Survey 
Social Capital Questionnaire (HLSSC) which showed that the peer support group 
had greater levels of perceived social capital at baseline compared to the control 
group. 
Table 3. Baseline measures of participants who completed the resilience 
outcome measure at 18 months in each study condition 
 
Baseline Measure Totala 
Peer 
Supportab 
N= 125 
Controlab 
N= 125 
Statistical 
Test (df) 
p 
Symptoms      
BPRS 43.35 (10.92) 42.76 (10.7)b 43.95 (11.13) t(246)= 0.86 0.38 
Social Capital     
Social Outcomes 
Index (Six) 
3.83 (1.37) 3.80 (1.36) b 3.86 (1.39) t(246) = 0.39 0.70 
UCLA Loneliness 22.1 (4.5) 21.92 (4.6) 22.29 (4.4) t(248) 0.65 0.52 
Lubben Social 
Network Scale 
11.20 (5.86) 11.04 (5.52) 11.42 (6.19) t(248) = 0.51 0.61 
Health and Lifestyles 
Survey Social Capital 
Questionnaire 
2.62 (2.81) 3.02 (2.41)b 2.24 (3.10) t(246) = -2.19 0.03* 
Recovery      
Questionnaire on 
Process of Recovery 
52.39 (16.19) 53.86 (16.39)b 50.94(15.94) t(246) = -1.42 0.17 
Illness Management 
and recovery 
46.5 (6.98) 47.1 (6.63)b 45.86(7.28)b T(241) = -1.38 0.17 
 
a All results are M (SD) unless otherwise indicated 
b Variations in N due to missing data 
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Lastly, the participants who completed the measure of resilience (CD-RISC-
10) at 18 months were compared to those that did not go on to complete the study; 
that is those that dropped out prior to this 18-month time point. There was no 
difference between the 18-month completers and the main trial group in terms of 
age, gender, and diagnosis (Table 4). 
 
Table 4. Comparison of baseline characteristics of completers and drop-outs 
 
Variable 
Total+ 
Completers 
N=250 
Dropped Out 
N=148 
Statistical 
Test (df) 
p 
Age M(SD) 
40.2 
(12.9) 
40.0 (12.31) 40.5 (13.96) t(396) = -0.45 0.71 
Gender      
Male 
Female 
160 (40) 
238 (60) 
101 (40) 
149 (60) 
59 (40) 
89 (60) 
2 (1) = 0.01 0.92 
 
Diagnosis 
     
Psychosis 106 (27) 60 (25) 46 (30) 2 (4) = 4.23 0.38 
Bipolar Affective Disorder 
(Manic Episode) 
64 (16) 41 (17) 23 (16)   
Depressive/Anxiety Disorder 137 (35) 88 (36) 49 (33)   
Personality Disorders 52 (13) 37 (15) 15 (10)   
Other 33 (8) 18 (7) 15 (11)   
+ All results are n (%) unless otherwise indicated 
 
Furthermore, an analysis was carried out to investigate if people allocated to 
one arm of the study, either the treatment or control arm, were more likely to drop 
out prior to 18 months data collection. Again, there was no significant difference 
between those that dropped out prior to the 18-month data collection time point in 
terms of receiving the intervention or not and those that went on to complete 
outcome data collection at 18 months (Table 5). 
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Table 5 Association between treatment allocation and drop-outs 
Intervention 
Arm 
Completers 
N (%) 
Dropped out 
N (%) 
Total Statistic 
Peer support 125 (50.2) 76 (49.35) 201 (49.88) x2 (1)= 0.004, p= 0.95 
Control 125 (50.0) 77 (50.33) 202 (50.12)  
Total 250 153 403  
 
Effect of Peer Support self-management intervention on resilience 
In terms of the primary outcome variable, resilience, contrary to the 
hypothesis, there was no significant difference between those participants who 
received the peer support intervention (M= 22.40; SD 8.94) and those that did not 
(M= 20.22; SD 9.58); t(248)= -1.86; p=0.06, d=0.24). 
 
Univariate and multivariate analysis of predictors of resilience at 18 months 
A correlation matrix of outcome variables revealed no significant correlation 
between resilience and demographic characteristics: age, gender, length of contact 
with services, diagnosis and educational attainment. As anticipated there was a 
small but significant correlation between resilience and those with a psychotic 
disorder (compared to those with an affective disorder), which was accounted for in 
the a priori fixed effects of the multilevel model. The clinical predictor outcome 
variables were all associated with resilience. An example of these associations is 
illustrated in linear relationship between QPR and CD-RISC-10 is illustrated (Figure 
2). The two measures of recovery, the QPR and IMR were inter-correlated (r= 0.61), 
confirming that they are indeed measuring the same construct. Consequently, the 
IMR measure was dropped, and QPR, a more general measure of recovery, was 
retained. 
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Figure 2. Scatterplot of resilience (CD-RISC-10) at 18 months and baseline 
measure of recovery (QPR) 
 
A multi-level model of the outcome resilience, with a priori fixed effects for 
treatment arm, severity of mental health (psychosis or not) and NHS trust was 
created controlling for random effects of clustering at the level of the peer support 
worker. Univariate analysis of each predictor variable was conducted (Table 6). Q 
plots were generated and residuals were considered near normal. Variables that 
were found to have a statistically significant effect on resilience were entered into 
the multivariate random effects model (Table 7). 
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Table 6. Univariate predictors of resilience after 18 months post discharge 
from CRT care 
   Univariate 
 N r B (95% CI) p 
Age 250 0.09a 0.07 (-0.02 – 0.16) 0.13 
Gender     
Male 
250 
 Ref Ref 
Female 0.09b -2.01 (-4.46 – 0.31) 0.10 
Education Level     
School level qualification  Ref Ref Ref 
Post school qualification  0.04b 0.83 (-1.48 – 3.14) 0.48 
Length of Contact with Services     
≤ 5 years contact 
250 
Ref Ref Ref 
> 6years contact 0.02b -0.49(-2.79 – 1.81) 0.67 
Intervention Group      
Control  Ref Ref Ref 
Peer support intervention  0.12b 2.02 (-0.41 – 4.45) 0.10 
NHS trust     
Camden & Islington 250 0.01b Ref Ref 
NELFT   -1.24 (-4.80 – 2.31 0.49 
SLAM   0.67 (-3.11 – 4.45) 0.73 
WLMHT   0.60 (-5.7 – 6.96) 0.85 
AWP   2.24 (-1.61 – 6.10) 0.25 
SABP   -1.65 (-6.43 – 3.12) 0.50 
Severe Mental Illness     
Non-psychosis 
250 
Ref Ref Ref 
Psychosis 0.14* b 3.11 (0.85 – 5.38) 0.007* 
Clinical Outcomes     
Symptom Severity (BPRS) 248 -0.32*a -0.27 (-0.37 – -0.17) <0.001* 
Social Outcomes Index (Six) 248 0.22*a 1.53 (0.71 – 2.35) <0.001* 
UCLA Loneliness 250 -0.35*a -0.72 (-0.95 – -0.48) <0.001* 
Lubben Social Network Scale 250 0.23*a 0.39 (0.20 – 0.58) <0.001* 
Neighbourhood Social Capital 
(HLSSC) 248 0.30*a 0.99 (0.60 – 1.38) <0.001* 
Questionnaire on Process of Recovery 248 0.52*a 0.30 (0.24 – 0.36) <0.001* 
Illness Management and recovery 243 0.30*a 0.40 (0.24 – 0.56) <0.001* 
aPearson’s correlation coefficient 
bSpearmans rank order correlation 
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Table 7. Multivariate predictors of resilience after 18 months post discharge 
from CRT care 
 Multivariate 
 β (95% CI) p 
Intervention Group    
Control Ref Ref 
Peer support intervention 0.97 (-1.17 – 3.11) 0.37 
NHS trust   
Camden & Islington Ref Ref 
NELFT -1.43(-4.46 – 1.62) 0.36 
SLAM -1.52(-4.76 – 1.72) 0.36 
WLMHT -0.68(-6.15 – 4.78) 0.81 
AWP 0.82 (-2.44 – 4.08) 0.62 
SABP -0.75 (-4.95 – 3.45) 0.73 
Severe Mental Illness   
Non-psychosis Ref Ref 
Psychosis 1.54 (-0.56 – 3.62) 0.15 
Clinical Outcomes   
Symptom Severity (BPRS) -0.03 (-0.14 – 0.08) 0.60 
Social Outcomes Index (SIX) 0.93 (0.12 – 1.75) 0.03* 
UCLA Loneliness 0.01 (-0.30 – 0.32) 0.95 
Lubben Social Network Scale 0.01 (-0.21 – 0.20) 0.94 
Neighbourhood Social Capital (HLSSC) 0.36 (-0.03 – 0.74) 0.06 
Questionnaire on Process of Recovery 0.25 (0.18 – 0.33) <0.001* 
Note: N= 242 
 
 
The coefficients for each of the variables in Table 7 indicates the amount of 
change one could expect in resilience given a one-unit change in the value of that 
predictor variable, given that all other variables in the model are held constant. From 
the multilevel modelling (Table 7) two baseline predictors of resilience were 
identified. A one-unit increase in social capital/connectedness as measured in the 
SIX results in a 0.93-point increase in resilience. A one-unit increase in recovery as 
measured on the QPR will result in a 0.25-point increase in resilience. No other 
baseline factors were found to be predictive of resilience.  
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Discussion 
The main finding in this study was that, contrary to the hypothesis, there was 
no effect of peer support on resilience at 18 months post-randomisation. This is 
consistent with previous findings which have not shown an effect of peer support on 
symptomatic measures (Lloyd-Evans et al., 2014) but is in contrast to qualitative 
studies that report positive effects (Castelein et al., 2015; Gillard, Edwards, Gibson, 
Owen, & Wright, 2013; Gillard, Foster, & Turner, 2016). Unfortunately, the overall 
findings of the CORE trial are not currently available. This means it is not possible to 
assess how the lack of effect of peer support on resilience fits with the other 
outcomes under investigation in the trial, such as readmission rates, effect on 
symptomology, social outcomes and participants’ subjective sense of recovery.  
 The present study also found that a SMI diagnosis (psychosis or bipolar) 
was associated with higher levels of resilience. This is perhaps not what one would 
expect given the significant challenges those with SMI can experience. Though a 
key aspect of resilience, that it develops in the context of overcoming adversity, 
could account for the difference in resilience in this group (Rutten et al., 2013). 
However, the level of resilience in participants in this study was considerably lower 
compared to the mean (31.78) reported in a general adult population sample 
(Campbell-Sills, Forde, & Stein, 2009).  
This study contributes to the literature on resilience by examining clinical and 
social predictors of resilience in a population with significant mental health 
difficulties: a question that has not previously been investigated. This study found 
that all baseline clinical outcome variables measuring symptoms, social capital and 
recovery were significantly associated with resilience 18 months later. It is not 
surprising that people with less symptomatology, more social links and a greater 
perceived level of recovery have higher levels of resilience. However, when all of 
these variables were entered into the random-effects multi-level model (taking into 
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account clustering at the peer support worker level, and a priori effects of diagnosis, 
NHS trust, and treatment arm) only two variables were found to be predictive of a 
resilient outcome: Social Outcomes Index (SIX, which measures employment, 
accommodation and social contact) and the Questionnaire about the Process of 
Recovery (QPR, which measures level of self-rated recovery). While these two 
variables were statistically significant in the model, the amount of change elicited is 
unlikely to be clinically meaningful in terms of resilience. 
The null findings of this study in relation to the provision of peer support are 
perhaps not surprising given that the typical population of clients in CRTs are seen 
at a time of high distress. This was reflected in the scores on the BPRS that showed 
at baseline; that is within one month of discharge from CRT care and at the time of 
randomisation, the mean symptom level could be classified as “moderately ill”. 
Additionally, this cohort is a group of individuals with enduring mental health 
difficulties, reflected by the large proportion having had contact with services for 
over 10 years. It may be that clients were still too unwell to fully benefit from support 
from a peer or to take on board and process the information presented in the 
recovery workbook. Furthermore, the development of resilience is not a simple 
linear trajectory but is the result of complex interrelated factors (Rutten et al., 2013), 
with disadvantage “not an event that strikes at a single point” (Graham & Power, 
2004, p.1) but instead has a cumulative and ongoing impact on the development 
and utilisation of personal resources. The reality of effecting change in resilience 
from a relatively brief intervention may have been overly ambitious.  
Limitations 
One major limitation of this study is that the primary outcome variable, 
resilience, was added late in the study design, and therefore data was only available 
at the 18-month measurement point. This meant that there was no control for 
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potential post randomisation group differences in this variable. Additionally, it was 
not possible to adjust for baseline resilience which means it is not possible to 
differentiate if baseline SIX and QPR are significant predictors or just highly 
correlated. Joining the CORE research programme later on also meant that there 
were other aspects of the research that may have been fruitful to explore but were 
not possible. For instance, it would have been interesting to collect more detailed 
information on the peer support workers themselves, including a measure of 
resilience, to investigate if those considered recovered did actually exhibit higher 
levels of resilience. Demographic characteristics of the peer support workers were 
gathered, but unfortunately were not available for use in this thesis. Furthermore, it 
could have been informative to elicit the views of peer support workers themselves 
to get their perspectives on the intervention, and what they think may or may not 
have been working for participants. It would have also been useful to analyse what 
the characteristics of more successful peer relationships were, but unfortunately at 
the time of writing, these data were not available. 
Another limitation is related to the selective participant sample. While this 
study endeavoured to recruit a sample that was representative of service users from 
NHS crisis resolution teams, it is likely the sample was subject to both selection and 
attrition bias. For instance, the eligibility criteria for the study meant that many 
potential participants were excluded on the basis of capacity to consent, or due to 
risk. Since those with capacity or risk issues are also likely to be more unwell, then 
their exclusion may have resulted in an unrepresentative sample. Furthermore, a 
third of participants randomised to the intervention arm did not receive it. Reasons 
for withdrawal from the study included participants being unable to be contacted by 
research staff, withdrawing before the first peer meeting, or discontinuing after 1 or 2 
sessions. This attrition suggests the resulting cohort who completed the study may 
have consisted not only of those who were functionally doing better, but also those 
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who may have felt more positive about peer support or were more open to building 
social connections. 
In relation to the measurements used in this study most were self-rated (with 
the exception of the BPRS) and only two focused on recovery oriented outcomes 
(IMR and QPR). While these do tap the recovery constructs of hope, empowerment, 
self-efficacy and sense of purpose, the study could have benefited from more 
specific measures of these constructs. Additionally, there was a large focus on the 
outcomes related to social connectedness, and while this is valuable to explore 
(having previously been linked with recovery and resilience; Ozbay et al., 2007), this 
focus could have impacted on participants by highlighting areas of their lives where 
they experience a deficit (i.e. in social connectedness). Adding recovery measures 
of hope and empowerment could be a counter to this deficit focus from the social 
capital questionnaires. 
As is common in this type of complex intervention, maintaining blinding of 
researchers who conducted the follow-up interview can be challenging. Every effort 
was made to remind participants not to reveal to the research staff if they had 
received a peer support worker, though it is inevitable that some participants would 
inadvertently disclose details that indicated their allocation status. 
Strengths 
A major strength of this study was its large sample size of 250 participants 
who were representative of a typical clinical population presenting for CRT care. 
Analyses of attrition of patients not participating in the 18 month follow up showed that 
those actually participating were not a select group, nor were they different to those 
who dropped out in terms of baseline characteristics further confirming the 
generalisability of the study population. A second strength of the study is the longer 
term follow up; previous studies have had much shorter follow up periods.  
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The programme also benefited from extensive input from service users in its 
design. At all stages of the research, from intervention design to delivery, service user 
contributions were sought and incorporated through focus groups, piloting of 
procedures, establishment of a consumer lead working group and employment of a 
service user “Public involvement coordinator” to offer guidance for the peer support 
workers who delivered the intervention.  
Clinical and Research Implications 
Clinically, the empirical evidence for peer support remains mixed. Some 
evidence has been positive but this tended to be from studies of moderate to low 
quality (Chinman et al., 2014; Pitt et al., 2013), or for select outcomes only (Lloyd-
Evans et al., 2014). The present study did not demonstrate any effect of peer 
support on resilience. The fact that peer support provision has persisted and 
continues to grow (Pitt et al., 2013) despite the paucity of consistent evidence 
supporting its use, suggests that at some level, peer support is meeting a need. 
Whether this need is a gap in current service provision or in a sense of 
connectedness that is rapidly becoming rare in our disconnected communities and 
under-resourced, time-pressed health service. Additionally, this is a need specific to 
those with severe mental illness, who are disproportionately affected amongst those 
with mental illnesses with social isolation due to stigma, and the social deficits 
inherent in SMI (Castelein et al., 2015). Peer support may be a way of reaching 
clients that services currently struggle to engage and a way to provide a meaningful 
partnership to develop their ability and confidence to manage their illness. 
In terms of further research, as mentioned in the limitations, it could be 
useful to gather the perspectives of peers, staff and participants themselves on how 
they feel they are managing following a peer-support intervention. Future studies 
that better differentiate the unique contribution of peers to the recovery process are 
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needed. Intuitively, peer support should be beneficial, and qualitative reports support 
this, so it could be that the positive effects are not detected using the current type 
and focus of outcome measures. Thus, it might be important to take a more 
recovery oriented approach with less of a focus on outcomes deemed important to 
professionals in services, such as reduction in symptoms and admissions. Instead, 
more of a focus on outcomes important to users of services, such as hope, 
recovery, and empowerment, may better demonstrate the effects of peer support.  
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This final part of the thesis focuses on the challenges inherent in the design, 
delivery, evaluation and implementation of complex interventions. In addition to 
considering the empirical study in Part 2 of the thesis, I will also draw on my 
experience working as a research associate on two large mental-health, multicentre 
randomised controlled trials over the past 8 years and previously working in clinical 
trials and the natural sciences. These experiences, have led me to question the 
suitability of applying strict scientific methods to the study of complex mental health 
interventions. Although new interventions and approaches are clearly needed, 
questions arise such as: is this the best use of government funding, can we actually 
make the differences that we hope to make, measure the changes that we hope to 
see, and how much can an intervention at the individual level truly make a difference 
when systemic and social factors perpetuate the conditions that contribute to mental 
health difficulties? 
Before critically appraising this study, it is important to acknowledge the 
limitations of the term ‘Severe Mental Illness’ (SMI) used throughout this thesis. This 
is a much contested term, with no agreed definition. Some argue that all mental 
illnesses have the potential to be serious in terms of the implications and impact on 
individuals functioning and quality of life (National Registry of Evidence-based 
Programs and Practices, 2016). Furthermore, while the term SMI is designed to 
encompass a more chronic and persistent presentation, not all severe mental 
illnesses are chronic or persistent and recovery is a possibility (Slade & Longden, 
2015). Alternative terms to SMI include ‘serious mental illness’ (often used 
interchangeably), chronic mental disorders, and severe and persistent mental 
illness- all considered to be equally problematic. I continued with the use of this term 
(whilst acknowledging its limitations) for simplicity and in line with the nomenclature 
used in the psychiatry department that this research was conducted and the 
psychiatric literature where the use of this term is commonplace. 
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I will first address some specific practical challenges in this study and then 
move on to address some of the wider issues encountered. 
 
Practical challenges in the conduct of large complex interventions 
Recruitment 
As anticipated, recruitment in this study was a challenge: follow up was not 
only over a long time period, but also had to be extended by 3 months. There were 
also substantial gaps between follow up interviews with participants. Recruiting and 
retaining participants over any length of time will always be a challenge, however 
this specific population poses unique challenges. For instance, due to the stage and 
complexity of their illness, that is immediately following a crisis, often participants’ 
lives can be chaotic, compounded by issues with accommodation and employment. 
Several strategies were employed to minimise attrition: upon entry to the study, 
participants were asked to nominate family members, friends or involved staff whom 
researchers could contact if unable to contact the participant directly for follow up; 
and to give permission for researchers to seek data about their service use from 
other health service providers, if the participant has moved or records were 
otherwise unavailable from the Trust. Additionally, update letters asking participants 
to let the research team know if any contact details had changed were sent 
periodically to participants. When organising follow-up interviews, a varied schedule 
of phone contact, including after-hours contact, was used to maximise the ability to 
get hold of participants. A final follow-up rate of 60% was achieved in this study. 
This is a very good follow up for a study of this nature. 
 
Impact on the present study 
Delays with recruitment had a major effect on the present study. In my 
original research proposal, I intended to focus on social (i.e. demographic, social 
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and neighbourhood capital) predictors of outcomes (symptoms, relapse, 
readmission, functioning, self-rated recovery and resilience) at 18-months. 
Recruitment was scheduled to be completed in January 2017, which would allow 
time to complete data checks and allow me to access the trial data and conduct the 
analysis. Unfortunately, recruitment needed to be extended until March 2017. As 
such the full 18-month data required for my original proposal was not available for 
use at that point in time. As such, I reverted to a contingency plan that focused more 
narrowly on the effect of peer support on resilience, and investigating baseline 
predictors of resilience.  
 
Data management 
The difficulty of being unable to extract data easily from NHS patient records 
is one that needs to be highlighted. It is disappointing that we have a National 
Health Service, but in reality, its functioning is not truly national in the way one would 
expect. There is very little uniformity across the NHS, particularly in terms of 
information systems. This presents two issues: firstly, the administration of the study 
was challenging because the research was conducted across multiple research 
sites and trusts which meant multiple site-specific approvals and training were 
required for research staff (despite the ‘streamlined’ research passport system). 
Secondly, the lack of uniformity of the data received from patient records meant that 
a lot of manual retrieval and manipulation of data was required, which meant the 
data became more vulnerable to human error discussed above. This additional layer 
of bureaucracy and inadequacy of basic data retrieval from information systems in 
trusts takes valuable time and resources. This is a missed opportunity to benefit 
from the richness of such a large potential data set. 
Scandinavian Countries (Lynge, Sandegaard, & Rebolj, 2011; Webster, 
2014) along with Canada (Kisely, Adair, Lin, & Marriott, 2015) have nationally linked 
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data which is achieved through a personal identification number which enables 
anonymous linking of data across agencies.  This has recently been identified by an 
NHS England independent Mental Health Taskforce report: “The five year forward 
view for mental health” strategy (NHS England, 2016). This taskforce has identified 
“the inadequacy of good national mental health data and the failure to address this 
issue until recently has meant that decisions are taken and resources allocated 
without good information, perpetuating a lack of parity between physical and mental 
health care” (NHS England, 2016; p. 51). The taskforce goes on to conclude that the 
quality of mental health services and their ability to meet the needs of service users 
is reliant on the collection of routine data in an accurate, timely manner for every 
person with mental health difficulties receiving care and that this should be linked to 
other data public data sets such as physical and social care (NHS England, 2016). If 
such a dataset were available we would have a better understanding of areas of 
need. Not only would it make research studies like these much simpler (or even 
parts of them unnecessary), but it could also significantly contribute to clinical 
innovation and improvement of mental health services in the UK. 
 
Research Design Issues 
 The current study was conducted as a randomised controlled trial (RCT) in 
order to generate ‘gold standard’, definitive data on the effectiveness of peer 
support. Randomised controlled trials, despite their design however cannot be fully 
objective or definitive; there will always be power dynamics (financial, social and 
organisational) that influence the design, length of intervention, choice of 
comparators and outcome measures (Wolff, 2000; p.105). A particular weakness of 
RCT design in relation to mental health interventions is that the key concept of 
RCTs, control of confounders, is difficult to achieve in a complex social context that 
has no clear boundary (Wolff, 2000). Thus, when a trial result is negative it actually 
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leaves us with many questions: was the intervention inherently ineffective (due to 
the specific intervention in this trial or because all similar interventions are 
ineffective), was it inadequately implemented, or implemented in an inappropriate 
context, or whether the trial used inappropriate design, comparison groups or 
outcomes (Campbell et al., 2007)?  
A partial solution to these problems is to do a mixed methods study that 
combines both quantitative and qualitative data. Mixed methods designs have been 
widely recommended (Hill, Chui, & Baumann, 2013; Lewin, Glenton, & Oxman, 
2009) and are becoming standard with large RCTs. They can help inform 
researchers on how participants experienced the intervention or untangle potential 
mechanisms of action of the intervention (Lewin et al., 2009). A mixed methods 
design was used in the CORE study and qualitative interviews have been carried 
out. Unfortunately, I do not have access to this data for use here. 
It is only while searching the literature for my initial idea that RCTs may not 
be an ideal fit for socially complex mental health interventions that I have come 
across an alternative interpretation of the concept of self-management. Whilst 
completing my systematic review and during the peer support study, I understood 
self-management to be a way of liberating and empowering individuals to take 
control of their illness. Harper and Speed (2012) however argue that in actuality self-
management moves the responsibility for social factors such as unemployment, 
poverty and poor health onto individuals packaged as a problem of “self-care”, or 
lack thereof (Lemke, 2001). This can be compounded by large RCTs like the 
present study that further negate the systemic and social aspects, and firmly place 
the responsibility with the individual.  
Perhaps a wider, community-level peer based intervention could be a better 
target than one-to-one support. There are already some examples in practice, such 
as the ‘Gardening Project’ where men with mental health difficulties get together to 
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garden (Robinson, Raine, Robertson, Steen, & Day, 2015), and the ‘Coping 
Through Football Project’ (Mason & Holt, 2012) which aims to improve wellbeing 
and reduce social isolation for young people with SMI through football. In the CORE 
study, the fact that one-to-one support ends, and is conditional, in that peer 
supporters are instructed to have no further contact post-intervention, could be 
experienced quite negatively by service users. Group-based interventions, that 
offered more informal, ongoing meet-ups might link individual in with peers in a more 
organic way that fosters more lasting relationships and addresses issues of social 
isolation. 
 
Focus of intervention 
One of the aims of the CORE program was to develop a peer delivered self-
management intervention to “bridge the gap” between crisis and continuing care. On 
reflection, should a 10-week peer-support intervention be expected to fill a gap in 
services and reduce re-admission?  Particularly when it is unclear whether CRT 
care itself has actually reduced admissions and bed usage or if it is simply the 
reduction in bed numbers (on the expectation that CRT care would decrease the 
need; and in order to fund these new services) that bed usage has reduced (Lodge, 
2012). The other criticism of CRT care- again one that peer support was 
hypothesised may bridge the gap- was in terms of providing a sense of continuity of 
care to service users (Lodge, 2012).  Since the intervention was limited to ten 
sessions, it is important to assess how much can this type of intervention actually 
contribute to continuity of care, and what is the effect of the ending of the peer-
support relationship on service users. 
Potentially one of the benefits of peer support is that it is experienced as 
separate to mental health services; however, I wonder to what extent service users 
experienced the peer support worker as just another mental health worker coming 
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in, and ‘doing to’ rather than truly ‘doing with’ and being service-user led.  Peers 
were not matched to participants in terms of age, gender, diagnosis or experience of 
services. Whether this could have made a difference in terms of meaningful 
connection is still to be explored. Moreover, it is unknown whether mutuality of the 
relationship can develop when there may be a power dynamic present that is similar 
to that in services. It may be that interventions can never be truly service-user led 
and bespoke in a trial setting, where control and replicability is at the essence of its 
ability to assess effectiveness (Bird et al., 2014). 
 
Length of intervention and follow-up 
The timing and duration of an intervention in relation to expected rate and 
pattern of change is an important factor (Craig et al., 2006) that must be balanced 
against the pragmatics and cost of delivering such an intervention. The current 
emphasis on brief, time-limited interventions may be setting interventions up to fail 
from the start. From the systematic review in chapter 1, the average duration of a 
self-management intervention was 12 weeks, which is similar to the present study. 
However, the face-to-face contact time was 23 hours, more than twice the amount of 
contact that service users had with peers in this study. Accordingly, I feel the current 
study could probably have benefited from a longer intervention period. 
Particularly for the population in this study, the inherent complexity and 
variability in the clinical course of illness, means response to treatment can take 
from 1 to 2 years for progression from the acute to the recovery phase (Liberman & 
Kopelowicz, 2005). Subsequently, the need for support is not confined to the newly 
diagnosed, but is often an ongoing issue (Lodge, 2012). Moreover, recovery is 
typically defined as a process or journey that can take many years (Castelein, 
Bruggeman, Davidson, & Van Der Gaag, 2015) rather than a static outcome (Drake 
& Whitley, 2014).  
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Outcome Measures 
We currently do not have a good understanding of how peer support might 
work and if it does even work. Best scientific practice is to opt for objective 
measures of outcomes with sound psychometric properties. This does not translate 
well to concepts such as ‘recovery’ which are not linear (Slade & Longden, 2015), 
but heavily influenced by context such as socio-economic background, health 
service systems, the population, the prevalence and severity of the condition studied 
and how these factors change over time (Campbell et al., 2007). Outcomes such as 
relapse, in symptoms and readmission, often become the focus of research because 
they are more easily observable, and measured, than other outcomes. Fonagy 
(1999; p294) argues that symptoms are merely “proxy variables for the more 
important but far more slowly changing concerns of most patients, which have to do 
with work, family relationships, capacity for coping and general quality of life”. 
In relation to the specific outcomes in this thesis, that is resilience, it has 
been argued that mental health programmes confront a challenge building individual 
resilience within fractured local communities (Robinson et al., 2015). Furthermore, 
the focus on resilience in this study has the potential to further obfuscate the role 
that social injustice and inequalities play in mental ill health. Resilience in the 
modern positive psychology sense is a construct consisting of psychological 
processes and personal strengths that are considered to be protective or 
ameliorative in the face of adversity (Harper & Speed, 2013). This emphasis on 
positives and strengths necessitate the existence of negatives or weaknesses 
(Harper & Speed, 2013), and again pull focus on individual qualities that should be 
developed or changed and does little to address the structural causes of distress 
(Marmot, 2010). 
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Conclusion 
Slade and Longden (2015) state that in many research approaches there is 
an “assumption that mental illness resides in the person” and that the “continued 
effort to individualise socially-caused phenomena represents a reasoning bias in 
mental health research”. As a career-long researcher and, more recently, a clinician 
in training, this is an uncomfortable realisation. A world health organisation report 
reiterated that while there is much that can be done to improve mental health in the 
future, doing so will depend less on specific interventions and more on a policy sea 
change (Friedli, 2009). Accordingly, there has been a promising movement in 
clinical psychology recently: away from the therapy room and into the community to 
actively engage and intervene at a policy systems level to address social 
inequalities at the root of individual distress (Browne, 2016).  
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Appendix 1: PRISMA Search strategy 
 
 
 
 
 
 
1.1 Databases: Embase, Medline, PreMedline, PsycINFO 
Interface: OVID SP  
Search Strategy 
# searches 
1 "explode schizophrenia"/ or (psychosis$ or psychotic$).hw. 
2 1 use emez 
3 
paranoid disorders/ or exp psychotic disorders/ or exp schizophrenia/ or "schizophrenia 
and disorders with psychotic features"/ 
4 3 use mesz, prem 
5 exp psychosis/ or exp schizophrenia/ 
6 5 use psyh 
7 
((chronic$ or serious$ or sever$) adj2 mental$ adj2 (ill$ or disorder$)).ti,ab,hw,id. or 
(delusional disorder$ or hebephreni$ or oligophreni$ or psychoses or psychosis or 
psychotic$ or schizo$).ti,ab,id. 
8 akathisia/ or dyskinesia/ or neuroleptic malignant syndrome/ 
9 8 use emez 
10 
akathisia, drug-induced/ or dyskinesias/ or dyskinesia, drug-induced/ or neuroleptic 
malignant syndrome/ 
11 10 use mesz, prem 
12 akathisia/ or exp dyskinesia/ or neuroleptic malignant syndrome/ 
13 12 use psyh 
14 
(akathisi$ or acathisi$ or (neuroleptic$ and ((malignant and syndrome) or (movement adj2 
disorder))) or (tardiv$ and dyskine$)).ti,ab,id. or ((parkinsoni$ or neuroleptic 
induc$).ti,ab,id. not (parkinson$ and disease).ti.) 
15 or/2,4,6-7,9,11,13-14 
16 exp self care/ or self evaluation/ 
17 16 use emez 
18 self administration/ or self care/ or self-help groups/ or self medication/ 
PRISMA, database searches only: 
9547 records identified through database searching  
6365 records after duplicates removed 
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19 18 use mesz, prem 
20 
self care skills/ or self evaluation/ or exp self help techniques/ or self monitoring/ or self 
regulation/ or self reinforcement/ 
21 20 use psyh 
22 
((self adj (administer$ or assess$ or attribut$ or care or change or directed or efficacy or 
help$ or guide$ or instruct$ or manag$ or medicat$ or monitor$ or regulat$ or reinforc$ or 
re inforc$ or support$ or technique$ or therap$ or train$ or treat$)) or selfadminister$ or 
selfassess$ or selfattribut$ or selfcare or selfchange or selfdirected or selfefficacy or 
selfhelp$ or selfguide$ or selfinstruct$ or selfmanag$ or selfmedicat$ or selfmonitor$ or 
selfregulat$ or selfreinforc$ or self re inforc$ or selfsupport$ or selftechnique$ or 
selftherap$ or selftrain$ or selftreat$).ti,ab. 
23 
(expert patient$ or (hearing voices adj2 (group$ or network$ or support$)) or (minimal adj 
(contact or guidance)) or helpseek$ or (help$ adj2 seek$) or (mutual adj (aid$ or help or 
support$)) or recovery model$ or smart recovery).ti,ab. 
24 
health education/ or health literacy/ or health promotion/ or patient education/ or 
psychoeducation/ 
25 24 use emez 
26 
exp consumer health information/ or health education/ or health knowledge, attitudes, 
practice/ or health promotion/ or patient education as topic.sh. 
27 26 use mesz, prem 
28 
client education/ or health education/ or health knowledge/ or health literacy/ or health 
promotion/ or psychoeducation/ 
29 28 use psyh 
30 
(booklet$ or brochure$ or leaflet$ or pamphlet$ or poster$ or psychoeducat$ or psycho 
educat$ or workbook$ or work book$ or ((adult$ or client$ or consumer$ or health or 
inpatient$ or outpatient$ or participant$ or patient$ or service user$) adj2 (educat$ or 
focus$ or information$ or knowledge or learn$ or literac$ or promot$ or taught or teach$)) 
or empower$ or ((oral or printed or written) adj3 (material$ or inform$))).ti,ab. 
31 adaptive behavior/ 
32 31 use emez 
33 exp adaptation, psychological/ 
34 33 use mesz, prem 
35 adaptive behavior/ 
36 35 use psyh 
37 (((behav$ or psychologic$) adj3 (adapt$ or adjust$)) or cope or copes or coping).ti,ab. 
38 patient participation/ 
39 38 use emez 
40 exp consumer participation/ 
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41 40 use mesz, prem 
42 client participation/ 
43 42 use psyh 
44 
((adult$ or client$ or consumer$ or inpatient$ or outpatient$ or participant$ or patient$ or 
service user$) adj2 (involv$ or participat$)).ti,ab. 
45 or/17,19,21-23,25,27,29-30,32,34,36-37,39,41,43-44 
46 
exp "clinical trial (topic)"/ or exp clinical trial/ or crossover procedure/ or double blind 
procedure/ or placebo/ or randomization/ or random sample/ or single blind procedure/ 
47 46 use emez 
48 
exp clinical trial/ or cross-over studies/ or double-blind method/ or placebos/ or random 
allocation/ or "randomized controlled trials as topic"/ or single-blind method/ 
49 48 use mesz, prem 
50 (clinical trials or placebo or random sampling).sh,id. 
51 50 use psyh 
52 (clinical adj2 trial$).ti,ab. 
53 (crossover or cross over).ti,ab. 
54 
(((single$ or doubl$ or trebl$ or tripl$) adj2 blind$) or mask$ or dummy or doubleblind$ or 
singleblind$ or trebleblind$ or tripleblind$).ti,ab. 
55 (placebo$ or random$).ti,ab. 
56 treatment outcome$.md. use psyh 
57 animals/ not human$.mp. use emez 
58 animal$/ not human$/ use mesz, prem 
59 (animal not human).po. use psyh 
60 (or/47,49,51-56) not (or/57-59) 
61 15 and 45 and 60 
 
 
1.2. Database: CENTRAL Search strategy 
Interface: Wiley  
 
Search strategy: 
 
#1 mesh descriptor: [paranoid disorders] single term only  
#2 mesh descriptor: [schizophrenia and disorders with psychotic features] single term 
only 
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#3 mesh descriptor: [psychotic disorders] explode all trees  
#4 mesh descriptor: [schizophrenia] explode all trees 
#5 ((chronic* or sever*) and mental* and (ill* or disorder*)):ti,ab,kw   
#6 ("delusional disorder*" or hebephreni* or oligophreni* or psychoses or psychosis or 
psychotic* or schizo*):ti,ab   
#7 mesh descriptor: [akathisia, drug-induced] single mesh term 
#8 mesh descriptor: [dyskinesias] single mesh term 
#9 mesh descriptor: [dyskinesia, drug-induced] single mesh term 
#10 mesh descriptor: [neuroleptic malignant syndrome] single mesh term 
#11 (akathisi* or acathisi* or (neuroleptic* and ((malignant and syndrome) or (movement 
n2 disorder))) or (tardiv* and dyskine*)):ti 
#12 (akathisi* or acathisi* or (neuroleptic* and ((malignant and syndrome) or (movement 
n2 disorder))) or (tardiv* and dyskine*)):ab 
#13 mesh descriptor: [movement disorders] explode all trees  
#14 (parkinsoni* or "neuroleptic induc*"):ti,ab,kw   
#15  (parkinson* and disease):ti   
#16  #14 not #15   
#17  #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #16 
#18 mesh descriptor: [self administration] single mesh term 
#19  mesh descriptor: [self care] single mesh term  
#20  mesh descriptor: [self medication] single mesh term  
#21  mesh descriptor: [self-help groups] single mesh term  
#22 ((self near/1 (administer* or assess* or attribut* or care or change or directed or 
efficacy or help* or guide* or instruct* or manag* or medicat* or monitor* or regulat* or 
reinforc* or “re inforc*” or support* or technique* or therap* or train* or treat*)) or 
selfadminister* or selfassess* or selfattribut* or selfcare or selfchange or selfdirected 
or selfefficacy or selfhelp* or selfguide* or selfinstruct* or selfmanag* or selfmedicat* 
or selfmonitor* or selfregulat* or selfreinforc* or “self re inforc*” or selfsupport* or 
selftechnique* or selftherap* or selftrain* or selftreat*):ti   
#23 ((self near/1 (administer* or assess* or attribut* or care or change or directed or 
efficacy or help* or guide* or instruct* or manag* or medicat* or monitor* or regulat* or 
reinforc* or “re inforc*” or support* or technique* or therap* or train* or treat*)) or 
selfadminister* or selfassess* or selfattribut* or selfcare or selfchange or selfdirected 
or selfefficacy or selfhelp* or selfguide* or selfinstruct* or selfmanag* or selfmedicat* 
or selfmonitor* or selfregulat* or selfreinforc* or “self re inforc*” or selfsupport* or 
selftechnique* or selftherap* or selftrain* or selftreat*):ab   
#24 (“expert patient*” or (“hearing voices” near/2 (group* or network* or support*)) or 
(minimal near/1 (contact or guidance)) or helpseek* or (help* near/2 seek*) or (mutual 
near/1 (aid* or help or support*)) or “recovery model*” or “smart recovery”):ti   
#25 (“expert patient*” or (“hearing voices” near/2 (group* or network* or support*)) or 
(minimal near/1 (contact or guidance)) or helpseek* or (help* near/2 seek*) or (mutual 
near/1 (aid* or help or support*)) or “recovery model*” or “smart recovery”):ab   
#26  mesh descriptor: [consumer health information] explode all trees 
  
 
130 
#27  mesh descriptor: [health education] single mesh term  
#28  mesh descriptor: [health knowledge, attitudes, practice] single mesh term 
#29  mesh descriptor: [health promotion] single mesh term  
#30  mesh descriptor: [patient education as topic] single mesh term  
#31 (booklet* or brochure* or leaflet* or pamphlet* or poster* or psychoeducat* or “psycho 
educat*” or workbook* or “work book*” or ((adult* or client* or consumer* or health or 
inpatient* or outpatient* or participant* or patient* or “service user*”) near/2 (educat* 
or focus* or information* or knowledge or learn* or literac* or promot* or taught or 
teach*)) or empower* or ((oral or printed or written) near/3 (material* or inform*))):ti 
  
#32  (booklet* or brochure* or leaflet* or pamphlet* or poster* or psychoeducat* or “psycho 
educat*” or workbook* or “work book*” or ((adult* or client* or consumer* or health or 
inpatient* or outpatient* or participant* or patient* or “service user*”) near/2 (educat* 
or focus* or information* or knowledge or learn* or literac* or promot* or taught or 
teach*)) or empower* or ((oral or printed or written) near/3 (material* or inform*))):ab 
  
#33  mesh descriptor: [adaptation, psychological] single mesh term  
#34  (((behav* or psychologic*) near/5 (adapt* or adjust*)) or cope or copes or coping):ti 
  
#35  (((behav* or psychologic*) near/5 (adapt* or adjust*)) or cope or copes or coping):ab 
  
#36  mesh descriptor: [consumer participation] single mesh term  
#37 ((adult* or client* or consumer* or inpatient* or outpatient* or participant* or patient* or 
“service user*”) near/2 (involv* or participat*)):ti   
#38 ((adult* or client* or consumer* or inpatient* or outpatient* or participant* or patient* or 
“service user*”) near/2 (involv* or participat*)):ab   
#39 #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or 
#30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 
#40  #17 and #39   
 
 
1.3. Database: CINAHL Search strategy 
Interface: Ebsco Host 
 
Search strategy: 
 
s30  s9 and s19 and s29  
s29  s28 not s27  
s28  s20 or s21 or s22 or s23 or s24 or s25 or s26  
s27  (mh "animals") not (mh "human")  
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s26  (pt "clinical trial") or (pt "randomized controlled trial")  
s25  ti ( placebo* or random* ) or ab ( placebo* or random* )  
s24  
ti ( single blind* or double blind* or treble blind* or mask* or dummy* or singleblind* or 
doubleblind* or trebleblind* ) or ab ( single blind* or double blind* or treble blind* or 
mask* or dummy* or singleblind* or doubleblind* or trebleblind* )  
s23  ti ( crossover or cross over ) or ab ( crossover or cross over )  
s22  ti clinical n2 trial* or ab clinical n2 trial*  
s21  
(mh "crossover design") or (mh "placebos") or (mh "random assignment") or (mh 
"random sample")  
s20  (mh "clinical trials+")  
s19  s10 or s11 or s12 or s13 or s14 or s15 or s16 or s17 or s18  
s18  
ti ( ((adult* or client* or consumer* or inpatient* or outpatient* or participant* or patient* 
or service user*) n2 (involv* or participat*)) ) or ab ( ((adult* or client* or consumer* or 
inpatient* or outpatient* or participant* or patient* or service user*) n2 (involv* or 
participat*)) )  
s17  (mh "consumer participation")  
s16  
ti ( (((behav* or psychologic*) n3 (adapt* or adjust*)) or cope or copes or coping) ) or ab 
( (((behav* or psychologic*) n3 (adapt* or adjust*)) or cope or copes or coping) )  
s15  (mh "adaptation, psychological")  
s14  
ti ( (booklet* or brochure* or leaflet* or pamphlet* or poster* or psychoeducat* or “psycho 
educat*” or workbook* or “work book*” or ((adult* or client* or consumer* or health or 
inpatient* or outpatient* or participant* or patient* or “service user*”) n2 (educat* or 
focus* or information* or knowledge or learn* or literac* or promot* or taught or teach*)) 
or empower* or ((oral or printed or written) n3 (material* or inform*))) ) or ab ( (booklet* 
or brochure* or leaflet* or pamphlet* or poster* or psychoeducat* or “psycho educat*” 
or workbook* or “work book*” or ((adult* or client* or consumer* or health or inpatient* 
or outpatient* or participant* or patient* or “service user*”) n2 (educat* or focus* or 
information* or knowledge or learn* or literac* or promot* or taught or teach*)) or 
empower* or ((oral or printed or written) n3 (material* or inform*))) )  
s13  
(mh "consumer health information") or (mh "health education") or (mh "patient discharge 
education") or (mh "patient education") or (mh "patient education (iowa nic) (non-
cinahl)") or (mh "mental health promotion (saba ccc)") or (mh "health promotion") or (mh 
"health promotion (saba ccc)") or (mh "health knowledge") or (mh "health knowledge 
(iowa noc) (non-cinahl)") or (mh "health knowledge and behavior (iowa noc) (non-
cinahl)") or (mh "knowledge: health behaviors (iowa noc)")  
s12  
ti ( (“expert patient*” or (“hearing voices” n2 (group* or network* or support*)) or (minimal 
adj (contact or guidance)) or helpseek* or (help* n2 seek*) or (mutual n1 (aid* or help 
or support*)) or “recovery model*” or “smart recovery”) ) or ab ( (“expert patient*” or 
(“hearing voices” n2 (group* or network* or support*)) or (minimal adj (contact or 
guidance)) or helpseek* or (help* n2 seek*) or (mutual n1 (aid* or help or support*)) or 
“recovery model*” or “smart recovery”) )  
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s11  
ti ( ((self n1 (administer* or assess* or attribut* or care or change or directed or efficacy 
or help* or guide* or instruct* or manag* or medicat* or monitor* or regulat* or reinforc* 
or re inforc* or support* or technique* or therap* or train* or treat*)) or selfadminister* 
or selfassess* or selfattribut* or selfcare or selfchange or selfdirected or selfefficacy or 
selfhelp* or selfguide* or selfinstruct* or selfmanag* or selfmedicat* or selfmonitor* or 
selfregulat* or selfreinforc* or “self re inforc*” or selfsupport* or selftechnique* or 
selftherap* or selftrain* or selftreat*) ) or ab ( ((self n1 (administer* or assess* or attribut* 
or care or change or directed or efficacy or help* or guide* or instruct* or manag* or 
medicat* or monitor* or regulat* or reinforc* or re inforc* or support* or technique* or 
therap* or train* or treat*)) or selfadminister* or selfassess* or selfattribut* or selfcare or 
selfchange or selfdirected or selfefficacy or selfhelp* or selfguide* or selfinstruct* or 
selfmanag* or selfmedicat* or selfmonitor* or selfregulat* or selfreinforc* or “self re 
inforc*” or selfsupport* or selftechnique* or selftherap* or selftrain* or selftreat*) )  
s10  
(mh "self administration") or (mh "self care") or (mh "self care agency") or (mh "self 
medication")  
s9  s1 or s2 or s3 or s4 or s5 or s8  
s8  s6 not s7  
s7  ti parkinson* and disease  
s6  ti ( parkinsoni* or "neuroleptic induc*" ) or ab ( parkinsoni* or "neuroleptic induc*" )  
s5  
ti ( akathisi* or acathisi* or (neuroleptic* and ((malignant and syndrome) or (movement 
n2 disorder))) or (tardiv* and dyskine*) ) or ab ( akathisi* or acathisi* or (neuroleptic* 
and ((malignant and syndrome) or (movement n2 disorder))) or (tardiv* and dyskine*) )  
s4  
(mh "akathisia, drug-induced") or (mh "dyskinesia, drug-induced") or (mh "dyskinesias") 
or (mh "movement disorders+") or (mh "neuroleptic malignant syndrome")  
s3  
ti ( "delusional disorder*" or hebephreni* or oligophreni* or psychoses or psychosis or 
psychotic* or schizo* ) or ab ( "delusional disorder*" or hebephreni* or oligophreni* or 
psychoses or psychosis or psychotic* or schizo* )  
s2  
ti ( ((chronic* or sever*) and mental* and (ill* or disorder*)) ) or ab ( ((chronic* or sever*) 
and mental* and (ill* or disorder*)) ) or mw ( ((chronic* or sever*) and mental* and (ill* 
or disorder*)) )  
s1  
(mh "paranoid disorders") or (mh "psychotic disorders") or (mh "schizoaffective 
disorder") or (mh "schizophrenia+")  
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Appendix 2.  Full Risk of Bias Assessment 
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Appendix 3. Forest Plots for select outcomes of meta-analysis 
Positive and Negative symptoms 
 
3.1 Positive Symptoms: End of Treatment 
 
 
3.2 Positive Symptoms: Follow Up 
 
 
3.3 Negative Symptoms: End of treatment 
 
 
3.4 Negative Symptoms: Follow Up 
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Relapse and length of hospitalisation 
 
3.5 Length of admission at end of treatment 
 
3.6 Length of admission at follow-up 
 
3.7 Mean number of relapses (of symptoms or hospitalised) at end of treatment 
 
 
3.8 Mean number of relapses (of symptoms or hospitalised) at follow-up 
 
 
3.9 Total number of participants who relapsed during the study period at end of 
treatment 
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3.10 Total number of participants who relapsed during the study period at follow up 
 
Self-rated recovery outcomes 
Empowerment 
3.11 Empowerment at end of treatment 
 
3.12 Empowerment at follow-up 
 
Hope 
 
3.13 Hope at end of treatment 
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3.14 Hope at follow-up 
 
Self -Efficacy 
 
3.15 Self-efficacy at end of treatment 
 
3.16 Self-efficacy at follow up 
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Appendix 4 Funnel Plots for assessment of Publication Bias (of meta-analyses 
with 10 or more studies) 
 
4.1 Total Symptoms: Post Treatment 
  
     
 
 
4.2 Total Symptoms:  Follow Up 
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4.3 Functioning: post-treatment 
 
 
 
 
 
4.4 Functioning: Follow Up 
 
 
  
 
141 
Appendix 5. Post-hoc sub-group analysis of TAU only and active control 
studies 
 
Studies with treatment as usual control only 
 
5.1 Total Symptoms at end of treatment 
  
5.2 Total Symptoms at follow up 
 
5.3 Mean number of relapses at end of treatment 
 
5.4 Mean number of relapses at follow up 
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5.5 Total number of participants who relapsed at end of treatment 
No data available 
 
5.6 Total number of participants who relapsed at Follow up 
 
 
5.7 Length of hospitalisation at end of treatment 
 
 
5.8 Length of hospitalisation at follow up 
 
 
5.9 Self-rated recovery at end of treatment 
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5.10 Self-rated recovery at follow up 
 
 
5.11 Functioning at end of treatment 
 
 
5.12 Functioning at follow up 
 
 
5.13 Quality of life at end of treatment 
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5.14 Quality of life at follow up 
 
 
Studies with Active Control only 
 
5.15 Total Symptoms at end of treatment 
 
 
5.16 Total Symptoms at follow up 
 
 
5.17 Mean number of relapses end of treatment 
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5.18 Mean number of relapses at Follow up 
 
  
 
5.19 Total number of participants who relapsed at end of treatment 
 
 
5.20 Total number of participants who relapsed at Follow up 
 
 
5.21 Length of hospitalisation at end of treatment 
 
 
5.22 Length of hospitalisation at follow up 
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5.23 Recovery at end of treatment 
 
 
5.24 Recovery at follow up 
 
 
5.25 Functioning at end of treatment 
 
 
 
5.26 Functioning at follow up 
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5.27 Quality of life at end of treatment 
 
 
5.28 Quality of life at follow up 
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Appendix 6. Ethics Approval 
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Appendix 7. 18-month Ethics Approval 
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Appendix 8. Patient Information Statement and Informed Consent Form 
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SERVICE USER INFORMATION SHEET FOR CORE PHASE 3 TRIAL 
Version 4, 04 November 2015 
 
Study Title:  Optimising team functioning, preventing relapse and enhancing 
recovery in crisis resolution teams: the CORE programme (CRT Optimisation 
and RElapse prevention) 
 
Phase 3: a randomised controlled trial of a peer-provided, self-management 
programme for people leaving Crisis Resolution Team (CRT) services 
 
 
You are being invited to take part in a research study. Before you decide it is important 
for you to understand why the research is being done and what it will involve. Please 
take time to read the following information carefully and discuss it with others if you 
wish. Ask us if there is anything that is not clear or if you would like more information.  
 
 
What is the purpose of the study? 
Crisis Resolution Teams (CRTs) provide short-term support to people during a mental 
health crisis. In this study, we will test whether support from someone who has used 
mental health services themselves (peer support) will help people develop ways to 
manage problems and stay well. We will investigate whether this peer-provided help 
to develop your own recovery plan is more useful than just giving people a booklet 
with advice and suggestions of ways to help recovery. In both cases, the other 
services received will not be affected. We now want to see how you are getting on 18 
months after you first entered the study by completing another set of questionnaires 
with a researcher. 
 
 
Why have I been asked to take part? 
You have been invited to take part because you have used one of the CRTs 
participating in this study and have taken part in an early stage of the study. During 
this earlier stage you were randomly allocated to receive either a self-help recovery 
workbook or a peer support worker to help you work through the recovery booklet. 
During this earlier stage of the study you also indicated that you were happy to discuss 
further participation in the study with a researcher.   
 
 
Do I have to take part? 
It is completely up to you to decide whether or not you would like to take part. If you 
decide to take part you will be given this information sheet and asked to sign a consent 
form. If you do decide to take part you are still free to withdraw at any time and without 
giving a reason. A decision to withdraw at any time, or a decision not to take part, will 
not affect the standard of care you receive now or in the future. If a researcher is 
unable to contact you for the follow-up interview, or if you decide you do not want to 
take part in a follow up interview, the research team will continue to use information 
you have already provided and information from your patient records, unless you let 
the research team or mental health staff involved in your care know that you do not 
want this to happen. 
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What will happen if I take part? 
If you agree to take part in this research you will be asked to participate in a research 
interview (lasting about an hour) which will be held about 18 months after you first 
entered the study. The researcher who meets you for your follow-up interview will not 
know whether you were allocated to get a peer support worker and will ask you not to 
tell them. It is also possible that another researcher might want to contact you to 
conduct another in-depth interview up to 2 years from now. You can choose not to 
give this additional consent.A researcher will also collect information from your NHS 
patient records about what mental health services you have used since you join the 
study; however this will not need your active involvement.  More detailed information 
on the study that you have participated in previously is provided at the end of this 
information sheet. 
 
 
Taking Part in CORE Phase 3 18 month follow-up: What is involved? 
 
 
1. A researcher will tell you more about the study, answer any questions and 
send you an information sheet. 
 
V 
2. If you are still interested, the researcher will arrange to meet you, answer 
any further questions and take your written consent to take part. 
 
V 
3. The researcher will then complete an interview with you lasting about an 
hour, involving a number of questionnaires. You will be offered a gift of 
£20 for your time and help. 
 
 
What are the possible benefits of taking part? 
We hope that the peer-provided self management support will help people’s recovery, 
increase their satisfaction with services overall and reduce future use of crisis 
services. Reading through the study self-management booklet, even without meeting 
a peer support worker, may also be helpful to people. People who take part in this 
study are helping us to find out more about what support is useful for people following 
a mental health crisis. People will be offered a £20 gift in cash after the follow-up 
interview, to acknowledge their time and help with the study. 
 
What are the possible disadvantages of taking part? 
It is possible you will not find meeting with a researcher and completing the 
questionnaires helpful and this could be disappointing. Many people feel it is helpful 
to talk about their experiences but thinking about a recent crisis may raise issues that 
are distressing. If you find any topic in the questionnaire interview unhelpful or 
upsetting, you do not have to complete it and you are free to stop at any point.  
 
 
Will my taking part be kept confidential? 
All the information that is collected about you by the researchers during the research 
interviews will be kept strictly confidential and anonymised. The only circumstances 
in which a researcher would not maintain confidentiality is if you told a member of the 
research team something which made us believe there was a serious risk to your or 
someone else’s safety. In those circumstances, we would discuss our concerns with 
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staff at the Crisis Resolution Team you have used, who would decide whether any 
further action was required.  
 
 
Where can I get further information? 
If you require any further information or have any questions not answered by this 
information sheet, or if you have any comments or concerns, please do not hesitate 
to contact a member of the research team. The research team representatives could 
be the researcher who is conducting the interview or: 
 
Study Chief Investigator: Professor Sonia Johnson 
Division of Psychiatry, University College London 
 
 
 
Programme Manager:  Bryn Lloyd-Evans 
Division of Psychiatry, University College London 
  
 
 
For independent advice about participating in research or this study, please contact 
the Mental Health Research Network Patient and Public Involvement (PPI) section. 
This is a national organisation designed to support the involvement of service users 
and carers in research. 
 
 
What if I am unhappy with the research? 
If you change your mind about participating in the study, you can withdraw your 
consent at any time, in which case all information collected about you would be 
deleted and not used in the research. If you have any concerns about the way you 
have been treated during the course of the research, the researcher will be very happy 
to discuss this with you. You could also contact the Study Lead or the Programme 
manager, whose contact details are above. If you wish to complain formally, or have 
any unresolved concerns about any aspect of the way you have been approached or 
treated during the course of this study, you can contact your local NHS Advice and 
Complaints service:  
 
Advice and Complaints Service 
Camden and Islington NHS Foundation Trust 
FREEPOST 1st Class (LON 12613) 
London 
NW1 0YT 
 
Tel: 020 3317 3117 
E-mail: complaints@candi.nhs.uk  
 
What happens to the results of the research study? 
The results of the study will be written up in a report for the Department of Health. 
They are also likely to be reported in scientific journals, presentations at conferences 
and articles in other relevant magazines or web publications. None of these reports 
will contain any personal information from which you could be identified. The 
information about you collected by the researchers will be stored securely at 
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University College London and will be archived then destroyed after completion of the 
study. If you are interested in the study, a copy of the report will be made available to 
all participants and other local service users. 
 
Who is organising and funding the research? 
The research is being organised by Camden and Islington NHS Foundation Trust and 
carried out by a research team based mainly at University College London. It is funded 
by the NHS National Institute for Health Research. 
 
Who has reviewed the study? 
The study has been reviewed favourably by researchers in the UK with considerable 
research experience. It has ethical approval from the London Camden and Islington 
Research Ethics Committee (Ref: 12-LO-0988).  
 
 
 
 
 
Thank you for reading this information sheet 
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Additional Information 
 
A detailed description of the study is described below. There are four stages to 
the study, and stages 1 to 3 are now complete. We are asking you to participate in 
stage 4: 
 
1) Before the treatment stage (Groups A and B) 
Once you have talked initially to a member of staff from the Crisis Resolution Team 
about the study and agreed to be contacted by a researcher, a study researcher will 
contact you. This will take place just before or soon after your period of support from 
the Crisis Resolution Team ends. The researcher will tell you more about the study 
and discuss the pros and cons of taking part. If you are still interested, the researcher 
will send you an information sheet about the study and arrange to meet you at least 
two days later.  
 
If at this point you decide to take part, you will be asked to sign the study consent 
form. You will then complete an interview with the researcher lasting about an hour. 
The researcher will ask you about your background and what mental health services 
you have used. He or she will complete a number of questionnaires with you. These 
will ask about your satisfaction with mental health services and experience of care, 
how you feel your recovery is going, your mental health symptoms, your drug and 
alcohol use and your general health. You will only be able to enter the study if you are 
prepared to complete this interview and also give consent for the research team to 
access details of your diagnosis and your use of services over the coming year from 
your NHS patient records. When you sign your consent to take part in the study, you 
will also be asked to give consent to two more things: a) Being contacted by a 
researcher after the four month follow up interview for a further research interview. (A 
researcher would explain what any further interview involved and you would be able 
to decide separately whether you wanted to take part in any further interview then.) 
b) For a researcher to try to contact you via a family member or mental health staff 
member working with you, if unable to contact you directly for the four-month follow 
up interview. 
 
Following the interview with the researcher, you will be offered £20 as a cash gift to 
acknowledge your time and help with the study.  
 
We want to make sure that taking part in this study does not influence what other care 
you are offered by mental health services. For this reason, we will not let you or the 
Crisis Resolution Team know whether you have been allocated to the group who will 
be offered a peer support worker until you have been discharged from the Crisis 
Resolution Team. A researcher will contact you again once you have been discharged 
from the CRT to let you know which group you have been allocated to.  
 
2) The treatment stage (This is different for Groups A and B) 
 
Group A: A peer support worker – someone who has used mental health services 
themselves – will contact you to introduce themselves and arrange to meet. Meetings 
may take place at your home, in NHS premises or elsewhere and at times agreed 
between you and the peer support worker. Altogether you will be offered 10 weekly 
meetings of up to an hour. During these meetings, the peer support worker will go 
through with you a booklet with ideas to help you plan things you can do which may 
help your recovery and how you might increase the support available to you. Paper 
or electronic versions of the booklet may be available. The booklet will involve things 
you can discuss together in sessions and that you can do on your own between them. 
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The peer support worker will also discuss with you if and how you could involve any 
mental health staff and your family or other support people. You will decide with the 
peer support worker how much of the booklet you want to use and how quickly to work 
through it. There will be time to talk more generally with the peer support worker about 
how you are feeling, the crisis you’ve been through or your hopes for the future. 
 
Group B: The researcher will send you a booklet with ideas to help you plan things 
you could do to help your recovery and increase the support available to you. Paper 
or electronic versions of the booklet may be available. You will not be offered any help 
from the study team to use this booklet; however you could show it to any mental 
health staff or your family or other support people if you wish.  
 
3) The four month follow-up stage (Groups A and B) 
About 4 months after you agreed to take part in the study, a researcher will contact 
you again about meeting for another, follow-up research interview. The researcher 
will discuss the study with you again and explain to you what the follow-up interview 
would involve. If you agree, the researcher will arrange to meet you again, at least 
two days later. At this meeting you will be asked to give your written consent again. 
You will then complete an interview with the researcher, lasting about an hour and 
involving the same questionnaires you completed at the first research interview. You 
can choose not to participate in the follow-up interview, without giving a reason. If you 
are unwilling or unable to complete the follow-up interview, the research team would 
still use the other information about you collected for the study unless you withdraw 
your consent to take part in the study altogether. 
 
Following the interview with the researcher, you will be offered £20 as a cash gift to 
acknowledge your time and help with the study.  
 
The researcher who completes the follow-up interview with you will not know whether 
you were allocated to receive a peer support worker or not. The researcher will ask 
you to try not to let them know during the follow up interview. If you were allocated to 
receive a peer support worker, a different study researcher, who does know which 
group you were allocated to, will contact you by phone or email. You will be asked to 
complete one more brief questionnaire about how you found working with the peer 
support worker. This will be confidential in the same way as the previous interviews 
and will not be shared with the peer support worker. You can choose not to take part 
in this additional questionnaire without giving a reason. 
 
4) The Eighteen month follow-up stage (Groups A and B) 
About 18 months after you agreed to take part in the study, a researcher will contact 
you again about meeting for another, follow-up research interview. The researcher 
will discuss the study with you again and explain to you what the follow-up interview 
would involve. If you agree, the researcher will arrange to meet you again, at least 
two days later. At this meeting you will be asked to give your written consent again. 
You will then complete an interview with the researcher, lasting about an hour and 
involving the same questionnaires you completed at the first research interview. You 
can choose not to participate in the follow-up interview, without giving a reason. If you 
are unwilling or unable to complete the follow-up interview, the research team would 
still use the other information about you collected for the study unless you withdraw 
your consent to take part in the study altogether. 
 
Following the interview with the researcher, you will be offered £20 as a cash gift to 
acknowledge your time and help with the study.  
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The researcher who completes the follow-up interview with you will not know whether 
you were allocated to receive a peer support worker or not. The researcher will ask 
you to try not to let them know during the follow up interview.  
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CORE Phase 3: consent form for participation in randomised controlled trial of a peer-
provided, self-management intervention for people leaving Crisis Resolution Teams 
 
Version 4: 04 November 2015 
 
Study Title:  CORE: Crisis Team Optimisation and Relapse Prevention – Phase 3 
 
Principal Investigator: Professor Sonia Johnson, UCL,  
Research worker:  
 
 
1. I have read and understood the study information sheet dated 04 November 2015 
 
2. I have had the opportunity to ask questions about the study 
 
3. I understand that my participation is voluntary and that I can withdraw at any time, 
without giving any reason, without the services provided to me being affected. 
 
4. I understand that the Crisis Resolution Team (CRT) which supported me will be 
informed that I am taking part in the study.  
 
5. I agree to my GP being informed of my participation in the study                              
 
6. I consent to a researcher contacting a family member or a member of staff, if I have 
named them below, if this is necessary to make contact with me for tha study follow-
up interview.     
                                                                                                  
7. I consent to the information collected about me for this study being stored securely 
at University College London   
 
8. I understand that I will be offered a £20 gift in cash for my participation in the 
research interview, once I have taken part in it.   
 
 
 
9. I understand that relevant sections of my medical notes and data collected during 
the study may be looked at by individuals from regulatory authorities and/or the NHS 
Foundation Trust where it is relevant to my taking part in the research. I give 
permission for these individuals to have access to my records. 
 
10. I consent to the research team having access to information about my diagnosis and 
my use of mental health services from my electronic patient records. If information 
about my use of services is not available from my electronic patient records in the 
NHS Trust whose services I am currently using, I consent to study researchers 
collecting this information where possible from other NHS services. 
 
11. I consent to a researcher contacting me up to 2 years after my follow-up interview to 
ask me about taking part in a further research interview for this study, or a separate 
follow-on study relating to this one.  
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12. I agree to take part in the study 
 
My preferred contact details: 
 
Name: 
 
Address: 
 
 
Phone number(s): 
 
 
E-mail address: 
 
Preferred method of contact: 
  Phone 
  E-mail 
  Letter 
 
 
 
 
 
Contact details of family members or carers I am happy for a researcher to contact if 
necessary to contact me for a follow-up interview: 
(If possible, please provide details of any family members or carers whom researchers could contact 
if unable to contact you directly for a follow-up interview.) 
 
 Family contact #1 Family contact #2 
Name   
Relationship to 
participant 
  
Address 
 
 
 
  
Phone number(s) 
 
  
email 
 
  
 
 
 
Contact details of mental health staff working with me I am happy for a researcher to 
contact if necessary to contact me for a follow-up interview: 
(If possible, please provide details of any mental health staff whom researchers could 
contact if unable to contact you directly for a follow-up interview.) 
 
Name: 
 
Job title: 
 
Service: 
 
Contact details (if known) 
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I would like a copy of a report with the study findings when the study is over: 
  Yes 
  No 
 
 
 
Please sign this consent form below to confirm your consent to take part in the study 
 
 
 
 
 
_____________________            _____________        _____________ 
Name of participant                  Date                          Signature 
 
 
 
 
_____________________             _____________      _____________ 
Name of researcher                         Date                         Signature 
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Appendix 9. Recovery Workbook 
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Appendix 10: Full baseline interview schedule 
 
 
 
Removed due to copyright restrictions
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Appendix 11. Connor Davidson Resilience Scale (CD-RISC-10) 
 
 
 
 
Removed due to copyright restrictions. 
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Appendix 12.  Statement of Joint working 
 
While this project is not a traditional joint working D.Clin.Psy. project, it was 
part of a programme of research conducted within a large research team. Data 
collection assistance was provided by research assistants employed on the study, 
along with a PhD student who was investigating loneliness in this cohort using the 
UCLA Loneliness Scale (ULS-8), Lubben Social Network Scale (LSNS-6) and the 
HLS Social Capital questionnaires, which were also collected as part of the standard 
data collection for the CORE. There was sharing of data collection duties only.  My 
contribution to the work involved adding to the follow up research design with the 
addition of the resilience measure to the study protocol, along with obtaining 
substantial amendments to the existing ethics approval, and creating updated 
versions of the protocol, patient information statement, informed consent form and 
questionnaires for participating trusts. During data collection, I worked in a 
coordinator role overseeing progress of recruitment and data collection, providing 
consultation in relation to ways to streamline and increase recruitment. I also 
contributed to recruitment by contacting “difficult to reach” participants outside of 
business hours (i.e. in the early evening) to catch participants who may work during 
the day. All other aspects of the research were distinct and independent. 
 
